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       Although solid-phase microextraction (SPME) technique has gained wide 
applications from in vitro environmental investigations to in vivo 
pharmacokinetic studies, there are still challenges for utilizing SPME to track 
fast concentration change over time at a specific location in a heterogeneous 
system, such as studying the tissue- specific metabolism or bioaccumulation of 
pharmaceuticals in a living animal. In this case, th  technique must be adaptable 
for in situ analysis with highly temporal and spatial resolutins. The goal of the 
research presented was not only to address this issue but also to develop new 
analytical methods that were more effective for in vivo study using SPME. 
In order to improve the temporal resolution, fast SPME sampling technique 
based on pre-equilibrium extraction must be adopted. However, more efforts 
need to be placed into calibration so as to guarantee the accuracy of the analysis. 
In this thesis, firstly, the kinetic calibration was proposed for adsorptive SPME 
fibres that were widely used for biological samples, which paved the way for 
performing fast sampling for in vivo dynamic monitoring. Secondly, the kinetic 
calibration was applied for in vivo pharmacokinetic study with beagles, with 
which not only solid experimental evidence was obtained for the calibration 
theory, but also an example was shown to address th quantitative capability of 
in vivo SPME. The developed method showed comparable sensitivity to 
traditional blood analysis (linear range 5 – 2000 µg/L and limit of detection: 
5µg/L). Furthermore, the traditional kinetic calibration based on isotopically 
labelled standards was simplified to a single time-point calibration, and a single 
 iv
standard calibration was developed for multiple analytes.  Therefore, the fast in
vivo sampling could be accomplished in a simple but accurate measure; 
compared to the established equilibrium SPME technique, statistically no 
significant difference (P<0.05) was observed by using one-way ANOVA and 
the post-hoc Turkey’s test for multiple comparisons. 
The second aspect of the thesis addressed the spatial resolution of SPME 
for in situ analysis. Firstly, the sampling of the SPME with high spatial 
resolution was modeled with multilayered gel system with the mini-sized SPME 
fibres. The feasibility of the SPME for in vitro application was demonstrated by 
sampling in an onion bulb with heterogeneous structure. Afterwards, the 
miniaturized fibre was successfully applied to the in situ analysis of the 
concentration distribution of Ochratoxin A in semisol d cheese samples with 
acceptable sensitivity (Detection limit was 1.5 ng/mL and the linear range was 
1.5-500 ng/mL) and comparable accuracy to the standard methods such as 
liquid extraction and microdialysis. Finally, the in vivo application of the space- 
and time- resolved SPME was implemented to study the tissue-specific 
bioaccumulations of pharmaceuticals in fish adipose fins and muscle tissues. 
The results were validated by the standard method liquid extraction, and they 
were also comparable to the literature results. 
The research presented here demonstrated the application potential of the 
time-and space- resolved SPME for in situ dynamic and static analysis in a 
living system such as a beagle or fish, and in a non-living system such as a 
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1.1 General Introduction of Solid-Phase Microextraction (SPME) 
As a solvent-free sampling and sample preparation technique, Solid 
Phase Microextraction (SPME) technique was first introduced by Dr. Janusz 
Pawliszyn’s group in 1990.1 The basic idea is to use a small volume of the 
extraction phase, usually in the order of 1 microlit e or less, to extract 
analytes from the sample. Since its early development stage, SPME has been 
considered an important advancement for the extraction of volatile organic 
compounds from environmental samples, 1-3 which was significantly boosted 
by the development of Headspace SPME (Hs-SPME).4 By integrating 
sampling, sample pre-concentration, sample preparation and sample 
introduction into a single step, SPME provides many significant advantages 
over the traditional sample preparation methods, such as simplicity, 
portability, time-effectiveness and cost-effectiveness. Therefore, it is not 
only suitable for laboratory research but also for on-site field sampling. 
Moreover, with limited extraction amount, sampling can be performed in 
such a way that only a small portion of the total free compounds are 
removed from the system. Thus, the disturbance of the normal balance of 




analysis of very small tissue sites or samples.5-6 Last but not least, SPME 
provides a simple means to monitor the free concentration of the analytes in 
a complicated sample matrix.5-8 Usually, only the free concentration is the 
active portion in pharmaceutical and environmental studies. All these 
strengths offer it versatile applications, from environmental studies to food 
chemistry and pharmaceutical studies, and from in vitro monitoring to in 
vivo analysis. 9-12 
 
1.1.1 SPME Device  
The elementary SPME sampler consists of a support component and a 
small sized extraction phase. The support component of the early SPME 
samplers was usually a fused silica fiber; however, due to its fragility, the 
silica has been replaced by metal wire such as stainless steel wires of 
different size, i.e., those from Small Parts Inc. (Miami Lakes, FL), which 
offers more size options and also the robustness and durability of the fiber 
material.  
The most important component of the SPME sampler is the extraction 
phase. The extraction phase can be either high molecular weight polymeric 
liquid for absorption, similar to stationary phases in chromatographic 
column, or a solid sorbent for adsorption similar to the sorbent used in solid 




rubbery material polydimethylsiloxane (PDMS), which is considered a 
typical liquid coating since in physicochemical nature its extraction behavior 
is based on partitioning. On the contrary, there arsome solid coating 
materials, of which the extraction is based on adsorption, where the 
extraction of the analyte molecules just occurs on the porous surface of the 
coating, rather than uniformly partitioning into the extraction phase as 
absorption does.13 Currently, the commercially available liquid coating 
materials are PDMS and polyacrylate (PA), while the solid coating materials 
include PDMS/divinylbenzene (DVB), carbowax (CW)/DVB, carboxen 
(CAR)/PDMS, DVB/CAR/PDMS and CW/templated resin (TPR). The 
liquid coating SPME fiber is usually with higher capacity and good 
sensitivity, but also longer equilibrium time, whic an be deduced from the 















=             (1.01) 
where a is the time constant, Vf is the fiber volume, A is the surface area of 
the fiber, hs is the mass transfer coefficient of the analyte in the sample 
matrix, hf is the mass transfer coefficient of the analyte in the fiber coating, 
and K is the distribution coefficient of the analyte betw en the coating 
surface and the sample matrix.   
     When hf is much bigger than hs, hs/2 hf is close to zero, which gives 








a =                              (1.02) 
Since hs/ 2hf is always bigger than 0, the a value from eq.1.2 should be 
always bigger than the a value calculated from eq.1.01. As a result, it could 
be concluded that the solid coating should have longer equilibrium time 
(smaller time constant) than the liquid coating if all the conditions, such as 
fiber materials and agitation, are the same for the two types of fibers. Since 
the materials that make solid coatings are never th same as those for the 
liquid coatings, often the solid coating fiber exhibits fast adsorption kinetics 
and is suitable for fast sampling.15Another important advantage for solid 
coating SPME is that the appropriate fiber can be chosen to extract polar or 
ionic analytes and compatible for liquid chromatography, which then opens 
the possibility for using SPME for pharmaceutical analysis and further in 
vivo pharmacokinetic studies.16-21   
However, there are some limitations for the solid coating fibers. 
According to the theory of extraction by porous solid SPME coatings, the 
number of effective surface binding sites where adsorption can take place is 
limited.13 When all such sites are occupied, no more analyte mol cules can be 
extracted. This indicates that analyte extraction is a competitive process in 
which a molecule with higher affinity for the bindig sites can replace a 
molecule with lower affinity. As a result, the linear range of the probe is low 




competitive compounds, thus resulting in seriously affected calibration. This 
problem can be significant in complicated biological and environmental 
matrices such as whole blood or sewage water where many endogenous 
compounds exist.15,22-23 Therefore, it is necessary to evaluate the competition 
effect when using a solid coating in complicated sample matrix.  
For volatile analytes, SPME fibers could be directly injected into the 
gas chromatograph for quantification. The extracted analyte is thermally 
desorbed into the instrument in the injector and then transported into the 
column by the gaseous mobile phase. However, for nonvolatile compounds, 
the extracted analyte must be desorbed into an amount of appropriate liquid 
solvent, or referred to as desorption solution, usually some organic solvent 
in which the solubility of the analytes is high. Afterwards, the solvent is 
submitted to instrumental analysis, for example, th mobile phase solution 
for the liquid chromatograph could be used for chromatographic separation. 
In some cases when further concentration of the analyte in desorption 
solution is needed for the sake of improved sensitivity, the solvent is 
evaporated and the analyte is re-dissolved in a smaller mount of 
reconstitute-solution. In addition to increasing the analyte concentrations, 
the reconstitute-solution is more compatible to the dir ct instrumentation.    
 




The classic SPME sampling is based on the partitioning equilibrium of 
the target analytes between sample matrix and fibercoating. There are two 
types of sampling in terms of the extraction time: equilibrium sampling and 
pre-equilibrium sampling.  
Equilibrium SPME is the most established method. During the 
sampling process, the analytes are extracted by the fiber until a partitioning 
equilibrium is established between the sample matrix and the extraction 
phase. A linear relationship between the amount of analytes extracted, ne, 








=                 (1.03) 
where Vf and Vs are the volume of the fiber coating and the sample, 
respectively. Kfs is the fiber coating/sample distribution coefficient of the 
analyte.When Vs >> KfsVf, the eq 1.03 can be simplified to eq 1.04,  
ffse VKCn 0=                          (1.04)             
The strength of this method is its high sensitivity, since the possibly 
maximal amount of analytes is extracted at a certain concentration; but the 
weakness is that it has a long extraction time, sometimes from several hours 
to several days, depending on the sorbent material, matrix, temperature, and 
agitation. Therefore, it may lead to reduced temporal resolution when it is 




In order to achieve fast sampling, the pre-equilibrium extraction 
method was developed. The milestone is the finding of the quantitative 
relation between the extracted amount in pre-equilibrium extraction and that 
in equilibrium extraction by studying the absorption kinetics, shown as 





−−=              (1.05) 
where n is the amount of analyte in the extraction phase after sampling time 
t, ne is the amount of analyte in the extraction phase at quilibrium, a is the 
time constant that is dependent on the volume of the extraction phase and 
sample, mass transfer coefficients, distribution coefficients, and the surface 
area of the extraction phase. By combining this equation and the equation 
for equilibrium extraction, eq 1.03, the linear relationship between sample 
concentration and the amount of analyte extracted in pre-equilibrium 







=         (1.06) 
     It deserves noting that the pre-equilibrium extraction shortens the 
sampling time to achieve fast sampling, but the sensitivity and 
reproducibility are somewhat compromised, since the sensitivity of the 
SPME is positively proportional to the amount of analytes extracted, and the 




extraction to agitation of the sample matrix. Therefor , when performing fast 
sampling, the sensitivity and reproducibility should be evaluated to meet the 
experimental requirements.    
 
1.1.3 External Calibration versus Kinetic Calibration  
In principle, SPME is an equilibrium based sampling technique rather 
than an exhaustive extraction method; therefore the SPME results must be 
calibrated to obtain the concentration of the analyte in the sample. Generally, 
calibration helps relate the analytical signal of the analyte to the initial 
concentration of the analyte in the sample. Specifically for SPME, two types 
of calibration are needed subsequently to achieve the goal. The first stage is 
the calibration of instrument response. For example, using mass 
spectrometry (MS) as a detector, an external calibration curve needs to be 
constructed to calibrate the response factors that rel te the amount of analyte 
introduced into the instrument with its response. Afterwards, as 
demonstrated in Fig. 1.1, the linear regression calibration curve of 
instrument response against the quantities of injected standards is developed, 
through which the responses from different batches of samples can be 
calculated. 
      The second stage is the calibration for the sampling method, which is 
defined as a process that relates the amount of analyte extracted by the 




Currently, there are two important approaches to calibrate the SPME results: 
calibration curve method and standard-on-fiber method.  
Theoretically, the calibration curve method, also refe red to as the 
external calibration method, is applicable to both equilibrium extraction and 
pre-equilibrium extraction because the amount of analyte extracted is 
linearly proportional to the initial concentration f analyte in the sample. In 
spite of the inconvenient and tedious procedures associated with the 
preparation of the standard solutions and controlling the experimental 
conditions, usually, this method is simple, with the only requirement that all 
the experimental conditions for calibration should be the same as for the real 
sampling. However, it might be difficult or impossible to satisfy the 
requirement in some cases, such as in on-site fieldsampling or in vivo 
pharmacokinetic studies, where reproducing the experimental conditions in a 
































 Fig.1.1. Calibration of instrument responses of LC-MS/MS. The injected 
amounts of standards are 1, 20, 100, 400 pg of oxazepam. The y axis in the plot is 
the ratio of the peak area of every standard over th  peak area of the internal 
standard lorazepam. 
 
To address the inherent weakness of the calibration curve method, the 
kinetic calibration method,14,26 also termed as the on-fiber standardization 
technique,27 was developed. This method is based on the symmetric 
relationship between the absorption process of analytes from a sample 
matrix to the extraction phase, and the desorption process of pre-loaded 
standards from the extraction phase to the sample matrix. Thus, extraction of 
analytes can be calibrated by determining desorption of the pre-loaded 




phenomenon for both solid coating and liquid coating was observed and well 
explained by the diffusion based mass transfer model.14,28 Experimentally, 
this method is simpler than the calibration curve mthod. More importantly, 
the method compensates for the effects of agitation and the sample matrix, 
and it provides accurate quantification of target analytes, especially during 
on-site or in vivo sampling, where standard addition and external standard 
calibration methods are not practical to use.27-30  
The relationship of the absorption and desorption processes is 









                       (1.07) 
where, Q is the amount of standard remaining in the extraction phase after 
exposure of the extraction phase to the sample matrix for a sampling time, t, 
and q0 is the amount of standard that is pre-loaded in the extraction phase. In 
eq 1.07, ne can be easily calculated since n, q0, and Q can be determined 
through experiments. Afterwards, the initial concentration of the target 
analyte, C0, can be calculated according to eq 1.04 for on-site or in vivo 
sampling, where, Vs >> KfsVf is satisfied. 
 
1.2 In vivo SPME 
     There are several rationales for conducting in vivo analysis. 




in the real physiological environment of a living system, has scientific 
significance, especially when it is difficult to remove representive samples 
from the living system for study. For example, when mice blood and tissue 
are sampled for pharmacokinetic studies, usually a arge number of animals 
are needed to obtain profiles with sufficient data points, since the amount of 
blood or tissue that can be obtained from an individual animal is limited. If 
blood and tissue were not removed from mice, small number of animals 
would be enough and the quality of the data would be improved by reduced 
individual variation. In addition, if sampling can be performed in such a way 
that a small proportion of the total free compounds is removed, the 
disturbance of the normal balance of chemical components is avoided, since 
compounds of interest are not exhaustively extracted from the investigated 
system. This is called negligible SPME.5-6,12 On the contrary, if significant 
depletion of the free fraction takes place, it results in release of the bound 
fraction until a new associating equilibrium is established. This may 
engender the nondisruptive analysis of very small tissue sites or samples. 
Currently, ultrafiltration (UF) and microdialysis (MD) are widely used 
approaches for in vivo sampling31-35. However, these approaches are 
inconvenient for field sampling since the sampling systems require pumps, 
tubing and other appliances. In addition, for ultrafiltr tion, the sampling 
process affects the local dissociation equilibrium between the bound and free 




microdialysis, the sensitivity could be a concern since sample 
preconcentration is poor. 
The use of SPME in vivo can serve as an ideal alterna ive because it 
eliminates the above mentioned problems. For instance, SPME is a 
nonexhaustive extraction technique where the extracted analytes exist in 
equilibrium with the extracting phase and sample matrix. According to the 
SPME theory, above a certain sample size, sample volume does not impact 
the results 24. Therefore, it is not necessary to define a specific sample size 
for the analysis, which is very convenient for in vivo sampling. Additionally, 
SPME directly extracts a small fraction of free analyte. So, a negligible 
depletion of the free fraction occurs after extraction. Finally, the technology 
is amenable to miniaturization, and is useful for bth small living systems 
and microanalytical instruments or techniques. These advantages make 
SPME a promising analytical tool for in vivo analysis21,36. 
 
1.2.1 Requirements of the SPME for In vivo Applications 
    The in vivo applications usually set much higher requirements for both 
SPME fiber materials and sampling strategies thanin vitro applications.  
Firstly, the SPME fiber coating must be biocompatible. Currently, there 
is no solid research to evaluate the biocompatibility of any SPME fibers. 




is a well known biocompatible material used for fabrication of 
biosensors.37-38 Therefore, it is assumed that the PPY fiber is biocompatible 
without direct evidence supporting the biocompatibili y of PPY fibers for the 
SPME use. Indirect evidence of biocompatibility could be the half-year 
survival of the animals after the SPME treatment.  
Secondly, the linear range of the fiber extraction should be broad 
enough to cover the expected concentration range of analytes in blood, 
especially during the early stage or beginning of pharmacokinetic studies 
where blood concentrations are very high. For example, the C18-bonded 
silica-polyethylene glycol (PEG) probe has a broad dynamic range (0.5-2000 
µg/mL) for diazepam, nordiazepam and oxazepam that ensured detection 
over the sample concentration range in whole blood during the 
pharmacokinetic studies of diazepam.22-23  
Thirdly, the matrix effect should be considered. In fact, the matrix 
effect is the most complicated and difficult factor, and it can be classified 
into several categories. Generally, matrix binding, matrix competition, 
fouling effect, pH effect and salt effect are the commonly encountered 
matrix effects that affect the quantitative capability of SPME in biological 
samples and environmental samples.39-44 Currently, there are dozens of 
reports discussing the matrix binding and free concentrations, but only a 
little discussion about the competition effect.13 Actually, the competition 




coating fiber for in vivopharmacokinetic studies, where competition can 
come from the metabolites and the drug, due to the similarity of their 
molecular structures. It might also come from the complicated matrix, such 
as whole blood samples which contain endogenous compounds. Usually, the 
competition effect is the main problem associated with porous solid coating 
SPME, since, according to the developed theory, 13,45-47 the number of 
effective surface sites where adsorption can occur is limited. Thus, the 
extraction of analytes by solid coating SPME is a competitive process in 
which several similar molecules compete for one binding-site, and a 
molecule with a higher affinity for the surface can replace a molecule with a 
lower affinity. As a result, both the amount of target analyte extracted and 
the linear range of the extraction decrease, while t e decrease is dependent on 
the concentration of the competitors. An example could be the serious 
competition effect on PPY fibers that occurred at 50 µg/mL of oxazepam 
and diazepam during a sampling time of 10 s.22  
Fouling effect is an important aspect to be addressed for in vivo SPME. 
But there was little experimental research to study the fouling effect, 
although Dr. Hermens mentioned this in a resourceful review about using 
negligible depletion SPME to measure the free concentration.12 The 
characterization experiment for biofouling effect was conducted by 
comparing the extraction behaviors of the fibers in direct contact with and 




thermodynamic parameter, partitioning constant were compared between the 
tissue-treated fiber and non-treated fiber. For the home-made PDMS fibers 
used in fish–tissue sampling (Chapter 7), there was no change observed for 
the two parameters.   
Furthermore, the sensitivity of the SPME fiber is a factor that must be 
considered for quantitative analysis, since it determines the limit of detection 
and the accuracy of the method when the sample concentration is low, such 
as during the late-phase of the pharmacokinetic studies. Here, the sensitivity 
of the fiber is defined as the amount of analyte extracted in a given time, 
which is determined by the kinetics of the extraction, as shown by eq 1.05. 
In order to have high sensitivity, the fiber should have a fast equilibrium 
time, such as the C18-PEG and PPY fibers, for which the equilibrium times 
were around 5 min during static extraction in whole blood. Meanwhile, the 
partitioning coefficient (Kfs) should also be high enough to have good 
capacity for the analyte. Eq 1.06 shows that the sensitivity of the SPME, 
denoted by the fiber volume, sample volume, partition ng constant, time 
constant and sampling time. When the time is known, the fiber volume and 
partitioning constant determine the extracted amount of analyte from the 
sample matrix, while the sample volume affects a little, as evidenced by Eq 
1.04.  
In addition to the high sensitivity requirements for the SPME fiber 




Usually, when conducting in vivo analysis, such as, a pharmacokinetic study, 
the analyte’s concentration changes rapidly. In order to track the 
concentration profile, the analytical approach should have a fast response 
time. Specifically for SPME, the fast sampling is desired to obtain high 
temporal resolution. In most cases, pre-equilibrium extraction method is 
preferred over equilibrium extraction unless the equilibrium time of the fiber 
is quite short, for example, for C18-PEG fibers, the equilibrium time is ~ 5 
min in static extraction mode. But, usually, the equilibrium time is quite 
long, from several hours to days. 
Accordingly, to improve the temporal resolution and efficiency of the 
SPME technique, kinetic calibration was developed where pre-equilibrium 
sampling is conducted for dynamic monitoring. This involves the extraction 
of analytes from the sample to the SPME fiber, and then, it is calibrated by 
determining the desorption of the pre-loaded standards from the fiber to the 
sample matrix. This method is not only simpler than the calibration curve 
method, but also compensates for the effect of agitation, temperature and 
matrix, thus providing more accurate quantitation, especially for on-site and 
in vivo sampling.  
The equilibrium SPME coupled to external calibration is not suitable 
for in vivo SPME. The reason is that it is impossible to reproduce the in vivo 
experimental conditions in the laboratory when conducting an in vitro 




flow rate during an in vivo experiment.  In addition, it is often not easy to 
obtain enough blank sample matrix from the living or anism to prepare the 
standard solutions that are needed for the external calibration. For example, 
it was found that when conducting the pharmacokinetic studies in beagles, 
the composition of the commercially available whole blood was 
significantly different from the whole blood from the experimental animals 
(Chapter 3). The composition of the sample matrix would affect the matrix 
binding, fouling and competition for active sites, thus affecting the accurate 
calibration of the SPME. Moreover, increasing the sampling time and 
amount of extraction of free analytes may result in no -negligible depletion 
and significant disturbance to the system under study. Finally, only the 
SPME fibers that exhibit a fast equilibrium time can be used for equilibrium 
sampling; otherwise, temporal resolution may be lost f r the dynamic 
monitoring to follow fast metabolism processes, such as pharmacokinetic 
studies. 
But, it must be noted that equilibrium sampling coupled to external 
calibration could be feasible for in vivo SPME, as long as the requirements 
or parameters for fast equilibration could be satisfied, as mentioned above.  
 





The term “temporal resolution” was adopted to describe the 
requirement of fast sampling for dynamic monitoring of analytes in vivo. 
Here, the temporal resolution of the SPME technique is defined as its 
capability to accurately determine the sample concentrations at a specific 
time point on the continuum of time and clearly resolve two different 
concentrations temporally close to each other, for instance, to monitor the 
drug concentrations at the time points of “5 min” ad “10 min” after the 
drug administration in a pharmacokinetic study. In this case, the sampling 
time of the SPME fiber should be less than the duration between the two 
time-points (i.e., 5 min); otherwise, the SPME fibers cannot tell the 
difference if the sampling time is long, e.g, 10 min. Generally, the temporal 
resolution of the SPME is determined by its response time or extraction time. 
Therefore, to improve the temporal resolution, it is necessary to shorten the 
sampling time. As mentioned above, a SPME fiber with higher temporal 
resolution should have high sensitivity; thereby, it is capable of tracking the 
concentration change. The next task is to develop accur te calibration 
procedures in order to deliver accurate quantitative results. 
Another important aspect of performing in vivo studies is to improve 
the spatial resolution of the SPME fibers. In this study, the spatial resolution 
of an in situ sampling technique is defined as its capability to accurately 
determine the local concentrations of analytes and clearly resolve two 




improving spatial resolution is due to the fact that the uneven distribution of 
certain substance within a natural system is much more common than 
uniform distribution because of the heterogeneous nature of the system. 
Therefore, for tracking the dynamic physiochemical process of a chemical in 
a heterogeneous system, for example, studying the distribution of 
pharmaceuticals within a small-sized animal organ or plant tissue, it is not 
necessary to place the normal-sized SPME fiber through ut the whole organ 
or tissue to gain a spatially averaged concentration of the organ or tissue. In 
this case, the fiber should be small-sized, and thereby suitable for the in situ 
sampling on different spots within the organ or tissue.   
Generally, the spatial resolution of SPME is determined by the size of 
its extraction phase; so, it can be improved by reducing the fiber size. 
However, the sampling time, that determines the temporal resolution of the 
technique, should also be considered at the same tie, since the diffusion 
during a long sampling time tends to uniform the concentration distribution 
in the adjacent area, thus making spatial resolution meaningless. 
Consequently, for SPME experiments, the effect of reduced sampling time 
should be considered together with shrinking the fib r dimension. 
The space-resolved SPME usually results in negligible depletion of the 
analyte from the sample due to its short sampling tme and small-sized 




temporal resolution of a SPME fiber can be described as equivalent to the 






=            (1.08)    
where, Cs is the sample concentration, S is the cross section area of the fiber, 
L (instrumental detection limit) is the minimal amount of analyte that 
generates a meaningful signal with the instrument, lm is the minimal length 
of the fiber, and tm is the minimal time that generates a significant result. 
This equation indicates that the sampling time has a negative correlation 
with the fiber length when all the other conditions, including the cross 
section area of the fiber, are set. In addition, the spatial resolution and 
temporal resolution are related to the sample concentration, instrument 
sensitivity, the cross section area of the fiber, the partitioning coefficient and 
the time constant of the sampling. This is quite understandable, for example, 
when the sample concentration or the partitioning coefficient is high, it takes 
less time to extract the detectable amount of analytes; or even if the fiber is 
shorter, the extracted amount of analyte is still enough to be detected by the 
instrument. Furthermore, using an instrument with improved sensitivity, the 
size of the fiber and sampling time can be reduced.  
When the sampling time, t, is short as fast sampling, and the amount of 
analyte extracted is in the linear regime of the extraction time profile, eq 







l =               (1.09)  





mm =                (1.10)  
 This equation presents the linearly reverse correlation between the 
temporal and spatial resolution of a SPME sampling. On the other hand, it is 
important to consider the diffusion of the analyte molecules within the 
sample matrix as it determines the minimal sampling time that could be used 
for SPME in heterogeneous system. The diffusion could be described by the 
integral form of the Fick’s first law of diffusion  
tDx ∗= 22                       (1.11) 
where, x is the migration distance of the analyte via diffusion, and t is the 
time duration of the molecule migration via diffusion. While conducting a 
sampling, the distance of molecule migration in the sample matrix should be 
shorter than the fiber length so that the in situ sampling can be significant. 
Otherwise, the determined concentration is only a spatially averaged one in a 
large area since the sphere of molecule diffusion is larger than the probe size. 
From this perspective, the relation between fiber length and minimal time 
for an in situ sampling (e.g., when x = the spatial resolution or fiber length, 
lm) can be described as eq 1.12. 
mm tDl ∗= 2




For example, it is assumed that the diffusion coeffici nt of the drug molecules in a 
semisolid tissue sample matrix, e.g., muscle, is 10-9 m2/s, and the fiber length is 1 
mm. Then, the minimal sampling time could be calculated as 500 s or 8 min. 
Strictly, a sampling time more than 9 min is not an in situ study. Similarly, when 
the sampling time is set as, for example, 10 s, the spatial resolution can be as high 
as 0.1 mm. There is no practicle significance of using 0.1 mm spatial resolution or 
fiber length for SPME sampling. However, it indicates that the fiber can be 
miniaturized that the invasiveness of the in vivo sampling can be further decreased. 
On the other hand, when D is large, e.g., for the volatile molecules in gas, 10-4 m2/s, 
and the sampling time is 100 s, the diffusion distance is more than 14 cm, thus 
making the spatial resolution meaningless.    
In summary, Eqs 1.08 to 1.10 describe the effect of SPME’s sensitivity 
(including fiber, sample concentration and instrument conditions) on the 
minimal fiber size and sampling time. But eq 1.11 presents the effect of the 
diffusivity of the analyte in the sample matrix on the spatial and temporal 
resolution. For a real sample analysis, both need att ntion and evaluation.  
 
1.3 Research Objectives  
The main objective of this dissertation is to improve the temporal 
resolution and spatial resolution of SPME and its applications. The research 




The first aspect addresses the temporal resolution of the SPME 
technique. The highly time-resolved SPME could be easily achieved by 
adopting a series of pre-equilibrium sampling procedur s coupled to the 
classic and simplified kinetic calibration methods. Therefore, the first work 
was the development of kinetic calibration for solid coating SPME, as 
described in Chapter 2. This part provides the foundation for the 
time-resolved pharmacokinetic studies. Then, the kinetic calibration with 
deuterated standards was applied to calibrate the in vivo sampling for 
pharmacokinetic studies, as described in Chapter 3. This work not only 
provided a solid experimental procedure to conduct quantitative in vivo 
analysis by SPME, but also presented a way to calibrate the pre-equilibrium 
extraction based on fast SPME. For further simplification of the fast SPME 
procedures, the non-deuterated standard calibration, the single time-point 
calibration, and the single standard calibration were proposed and discussed 
in Chapter 4. Therefore, the first section demonstrated that in vivo SPME 
could be accomplished rapidly, simply and cost-effectiv ly based on the 
understanding of the kinetic behavior of the in vivo SPME.  
The second aspect of the research is the development of the 
space-resolved SPME and its application to both in vitro and in vivo analysis. 
Firstly, as described in Chapter 5, the sampling of the SPME with high 




feasibility of the SPME for in vitro use was demonstrated using a 
heterogeneous system, an onion bulb. The second application, as described 
in Chapter 6, is the in situ sampling of the spatial distribution of Ochratoxin 
A, in a piece of semisolid cheese sample. The third investigation was an in 
vivo study of the tissue-specific bioaccumulations of pharmaceuticals in fish 
adipose fin and muscle tissue. The results are present d in Chapter 7. Finally, 
an overall summary of the scientific advancement from the work presented 
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In the recent years, solid phase microextraction (SPME) has gained 
extensive application and recognition in many areas. 1-3 It addresses the 
need for fast sampling and sample preparation for chromatography by 
integrating sampling, sample preparation and sample introduction into one 
step. With the development of simple but accurate kinetic calibration 
method,4-10 it shows unique potentialities in the field sampling, also called 
on-site sampling, and in vivo sampling as well.10, 11 In these cases, the 
effect of sample volume on the results of analysis can be neglected when 
the sample volume is much larger than the fiber capa ity KVf ( K = 
fiber/sample partition coefficient and Vf  = fiber volume). 
12, 13 
SPME fiber coatings can be classified into two distinctive types 
according to the mechanism of the extraction: absorption-type and 
adsorption-type. For absorption-type coatings, the extraction is based on 
partitioning of the target analyte between the extraction phase (the SPME 
fiber) and sample matrix, or in the fiber coating-sample-headspace ternary 
phase system, and either equilibrium extraction method or pre-equilibrium 
extraction method is applicable. The most established method is 
equilibrium extraction, where the fiber, coated with a liquid polymeric 
film, is placed in a sample matrix until a partition ng equilibrium is 
reached. The amount of analyte extracted by the fiber at equilibrium, ne, is 
 28








=                 (2.01) 
where, Vf and Vs are the volume of the fiber coating and the sample vo ume, 
respectively, and Kfs is the fiber coating/sample partition coefficient of the 
analyte. For on-site or in vivo sampling where Vs >>  KfsVf, the 
concentration of target analyte can be calculated by eq 2.02, the simplified 
form of eq 2.01. 2  
ffse VKCn 0=                      (2.02)             
External standard calibration method can be employed for 
quantification as long as the experimental conditions for calibration remain 
same as for the sampling. Usually the equilibrium extraction method 
provides the highest sensitivity because of the fact that the largest amount 
of analyte can be extracted out of the sample matrix. However, the 
extraction time might be too long to reach the equilibrium, thereby 
resulting in lower temporal resolution for kinetic monitoring. In addition, 
the equilibrium extraction method is not applicable for adsorption-type 
coating, also known as solid coating, where the extraction is based on the 
adsorption of the analyte onto the porous surface of the solid coating since 
the extracted amount of the analyte under equilibrium condition could be 
nonlinear with the initial concentration of the analyte in a sample of high 
concentration.14 In order to address these problems, Ai developed a 
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pre-equilibrium extraction method for SPME based on the finding that the 
amount of analyte extracted by the fiber before equilibrium, n, is also 
linearly dependent on the initial sample concentration, C0.
 15, 16 For 
quantification, however, the external standard calibr t on method is not 
applicable for pre-equilibrium extraction (for field or in vivo sampling), 
since it is difficult to keep the experimental conditions for calibration same 
as in field- or in vivo- sampling. In order to address the inherent 
incapability of the calibration curve method in this case, the kinetic 
calibration method,4-6 also called in-fiber standardization technique,7 was 
developed based on the symmetric relationship between the absorption 
process of analytes from sample matrix to the extraction phase and the 
desorption process of the preloaded standards from the extraction phase to 
the sample matrix. Therefore, the extraction of analytes can be calibrated 
by determining desorption of the preloaded standards (isotope labeled 
compounds are usually used as standards). This method compensates the 
effect of agitation, temperature and matrix, thus providing accurate 
quantification, and especially it is suitable for field- or in vivo sampling 
where standard addition and external standard calibration methods are not 
practical. 4-10  To date, all the studies for kinetic calibration have been only 
restricted within absorption-type of SPME fiber coatings4-6, 10 or pure 
liquid extraction phase in liquid phase microextraction (LPME), 7-9 without 
consideration of adsorption-type SPME coating. So, it is not practical to 
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apply the kinetic calibration method developed on absorption-type fiber to 
adsorption-type fiber coatings directly. Furthermore, although the kinetics 
of absorption and desorption process for liquid coating (absorption-type) 
SPME and LPME have well established theoretical basis for kinetic 
calibration, there is a lack for a mathematical description of the adsorption 
and desorption kinetics for adsorption-type SPME coating. Therefore, 
investigation of kinetics of adsorption and desorpti n and development of a 
kinetic calibration method for adsorption-type coating have unique 
theoretical importance and practice significance.  
 In this chapter, the kinetics of the adsorption and desorption onto and 
from the porous solid SPME coating are presented, meanwhile, the 
symmetric relationship between adsorption and desorption was 
demonstrated. In order to show its feasibility, the d veloped kinetic 
calibration method was successfully applied to correct the matrix and 
agitation effects in the drug analysis of clinical blood and plasma samples.   
 
2.2 THEORETICAL CONSIDERATIONS 
2.2.1 Adsorption Kinetics for adsorption-type SPME fibers 
When a SPME porous solid fiber is exposed to an agitated sample 
matrix, adsorption of the analytes from the sample to the fiber surface 
occurs (Figure 1, A). Compared to the three-layer model (analytes’ 
diffusion through a boundary layer, partition in the fiber/sample interface, 
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and then diffusion within the fiber coating) for absorption-type fiber,4,15 
such as the PDMS fiber, the model for adsorption only has two layers, 
where the analytes diffuse through the boundary layer nd then adsorb on 
the coating surface, without entering the inner part of the fiber. In 
experimental practice, it was reported that only negligible amount of 
analyte molecules entered the inner part of the solid c ating, while almost 
all analyte molecules adsorbed on the surface, during a brief extraction,14 
contrary to an extraction with liquid-coating SPME.  
The mass transfer of the analytes based on diffusion through the 
boundary layer is considered as the rate-determining step.18 Thus, Fick’s 
first law of diffusion (eq 2.03) can be applied to describe this process at the 













                        (2.03) 
where, J is the mass flux of the analyte from sample matrix to the fiber 
coating, A is the surface area of the fiber, ∂n is the amount of the analyte 
adsorbed to the fiber surface during time period of ∂t and Ds is the 
diffusion coefficient of the analyte in the sample matrix. A steady-state 
mass transfer can be established when agitation is applied effectively in the 
sample matrix. Therefore a linear concentration gradient in the boundary 



















                         (2.04) 
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where, δs is the thickness of the boundary layer, Cs is the concentration of 
the analyte in the bulk of the sample matrix, and Cs is the concentration 
of the analyte in the boundary layer at the interface of the fiber coating and 
the boundary layer. The mass transfer coefficient of the analyte in the fiber 
coating, hs, can be defined as Ds/δs, a constant for a steady-state diffusion 
process in an effectively agitated sample matrix. Thus, eq 2.04 can be 
rewritten as follows.  






                         (2.05) 
    At the interface of the fiber coating and the boundary layer, it is 
assumed that there is quick partition equilibrium for the analyte between 










                                 (2.06) 
where, K is the distribution coefficient of the analyte betw en the coating 
surface and the sample matrix, and Cf is the concentration of the analyte on 
the surface of the fiber coating. If it is assumed that the SPME coating has 
a uniform pore distribution and surface area through t its bulk, i.e., the 
surface area is linearly proportional to the volume of the coating, the 
concentration of the analyte on the surface of the fiber coating, Cf , can be 





C =                                           (2.07) 
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where, Vf is the fiber volume, and n is the extracted amount of analyte onto 
the surface of the fiber coating after the exposure tim  t. Thus Cs can be 




C ='                                         (2.08) 




CC −= 0                                    (2.09) 
where, C0 is the initial concentration of the analyte in the sample matrix, 
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a =                                          (2.12) 
Let 
0CAhb s=                                          (2.13) 
Then eq 2.10 can be simplified as  
bann =+'                                         (2.14) 
eq 2.14 can be solved with the initial condition: t = 0, n = 0 
( ) ( )[ ]atabn −−= exp1/                            (2.15) 
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Combination of  Eqs 2.12 and 2.13 gives 
0/ KCVab f=                                    (2.16) 
Substitution of eqs 2.16 and 2.2 into eq 2.15 gives 





−−= exp1                                 (2.18) 
where, t is the exposure time of the fiber into the sample, and a is the time 
constant that is used to describe how fast the equilibri m can be reached, 
as defined by eq 2.12. The value of a is dependent on the dimension of the 
fiber coating, mass transfer coefficients and distribu ion coefficients in a 




Figure 2.1. Interface of porous solid coating SPME fiber in contact with an 
aqueous solution. A steady-state diffusion is assumed in effectively agitated 
aqueous sample. The concentration gradient in the boundary layer is assumed to 

























2.2.2 Desorption Kinetics for adsorption-type SPME fibers 
When a SPME porous solid fiber, preloaded with an analyte, is exposed 
to an agitated sample matrix, desorption of the analyte from the coating 
surface to the sample occurs (Figure 1, B). The desorption process can be 
treated as the reversed process of the adsorption. S milarly, the equations for 
describing the desorption process can be derived based on the steady-state 
diffusion model, in brief,  





∂≡                          (2.19) 
where, ∂q is the amount of the analyte desorbed from the fibr surface 
during time period of ∂t. If the initial amount of analyte preloaded on the 
coating surface is q0, the remaining concentration of the analyte on the fib r 





−= 0                                      (2.20) 
where, q is the amount of analyte desorbed from the coating surface into the 




C =                                          (2.21) 
where, Cs is the concentration of the analyte in the sample matrix after time 
t.  
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At the interface of the fiber coating and the boundary layer, quick 
partition equilibrium of the analyte between the sample matrix and the 










                                 (2.22) 
where, K is the partition coefficient of the analyte between the coating 








−== 0'                                    (2.23) 





















+−=′                       (2.24) 
Using the same way as derivation of eq 2.11 to eq 2.16, Eq 2.24 can be 
solved and arranged as 
( )[ ]atqq −−= exp10                                   (2.25) 
in which, parameter a is defined in eq 12. If Q = q0 – q and Q is the amount 





                                     (2.26) 
 
2.2.3 The symmetric relationship of adsorption and desorption for 
adsorption-type SPME fibers 
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If the desorption and adsorption processes occur under the same 
experimental conditions, the time constant (a) should be the same or similar 
for the same compounds or similar compounds. Thus, the sum of Q/q0 (the 
fraction of the standard remaining on in the extraction phase after sampling 
time t) and n/ne (the fraction of the analyte adsorbed on the extraction phase 
after the same sampling time t) should be 1 at any desorption/absorption 









                              (2.27) 
Therefore, the symmetric relationship between the adsorption process and 
desorption process has been proved in theory.  
 
2.3 EXPERIMENTAL SECTION 
2.3.1 Chemicals and Supplies 
Benzodiazepines (diazepam, nordiazepam and oxazepam, 1 mg/mL in 
methanol) were chosen as the analytes and purchased from Cerilliant 
(Austin, TX, USA). These were diluted in methanol and phosphate-buffered 
saline (PBS) pH 7.4, or dog blood/plasma to use in instrument calibration 
and sample preparation, respectively. Lorazepam was used as the internal 
standard in sample preparation to calibrate the sample loss in sample 
preparation as well as sample introduction into the instrument. Beagle whole 
blood (EDTA as anticoagulant) was obtained from Biological Specialties 
Corp. (Colmar, PA, USA). Plasma was prepared with the whole blood by 
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centrifugation and stored frozen at -20 °C until use, and whole blood was 
stored at 4 °C.  HPLC grade acetonitrile and acetic acid (glacia) for HPLC 
mobile phase, methanol for desorption solution were bought from Fisher 
Scientific (Unionville, ON, Canada). Water was obtained from a Barnstead 
Nanopure water system.  
Polypyrrole (PPY) fibers that were extensively used for fabricating 
biosensors due to its conductivity and biocompatibility, were chosen as the 
model adsorption-type coating for drug analysis.19-20 The fibers with the 
same capacity were assumed to have the same surface a ea. It was verified 
that the extraction capacity is proportional to the porosity (as determined by 
scanning electron microscopy).  
All fibers used in the desorption experiments were p loaded with 
deuterated or nondeuterated standards. The loading solution was prepared by 
spiking deuterated standards (diazepam-d5, nordiazepam-d5 and 
oxazepam-d5) or non-deuterated standards into 25 mL of sterile 
deionized-water at 50 µg/L for each. Then the select d PPY fibers were 
exposed into the loading solution during 40 minutes for standard loading and 
then kept in tubes for use. 
  
 
2.3.2 Instrumental Analysis 
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A CTC-PAL autosampler/Shimadzu 10 AVP LC/MDS Sciex API 3000 
tandem MS system was used for the analysis of the drugs and their 
deuterated standards. The assay conditions were the same as described 
elsewhere,20 with the exception that the transition monitored for diazepam-d5 
was m/z 290.2/154.1. 
 
2.4 RESULTS AND DISCUSSION  
2.4.1 Verification of the kinetics of Adsorption and Desorption for PPY 
fibers 
In order to verify the kinetics of adsorption and desorption for porous 
solid fiber coating, absorption and desorption experim nts were conducted 
simultaneously. PPY fibers preloaded with deuterated diazepam were 
exposed to a flowing solution (linear flow velocity: 7.2 cm/s), diazepam in 
PBS (pH 7.4, 50 µg/L), for different times to study the time profile for 
absorption and desorption. Since, eqs 2.18 and 2.26 can be rewritten as Eqs 
















ln                       (2.29) 
the adsorption and desorption time profiles can be lin arized. 7 Figure 2 
illustrates the linearized adsorption and desorption me profiles at 25 oC 
(i.e., room temperature) where, ln(Q/q0) or ln(1- n/ne) is Y axis and – a is the 
 41
regression slope (from eqs 2.28 and 2.29). It showed a good linear 
relationship between ln (Q/q0) or ln (1- n/ne) and time (R
2 > 0.995). This 
result demonstrates that Eqs 2.18 and 2.26 accurately describe the kinetics of 
SPME desorption and absorption based on PPY fibers for drug analysis.  
 
A






































Figure 2.2. The adsorption time profiles (A) of diazepam and desorption time 
profiles (B) of diazepam-d5. The adsorption and desorption were performed in 
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standard solution prepared by PBS  (pH 7.4, 50 µg/L) in a flow system at a rate of 
7.2 cm/s and 25 ˚C. 
 
 
Figure 2.3 presents the values of Q/q0 calculated from the desorption 
time profile and n/ne calculated from the absorption time profile. The sum of 
Q/q0 and n/ne is close to 1 at each point (the range is 0.92-1.11), which 
























2.4.2 Pre-equilibrium extraction for Adsorption-type SPME 
As mentioned earlier that, equilibrium extraction method is not suitable 
for adsorption-type SPME due to the narrow linear range, competition effect 
for the limited binding sites and displacement effect between analytes and 
their analogues on the coating surface. 14 Thereby, pre-equilibrium 
extraction method is more desirable for solid coating SPME. When, eqs 2.01 
and 2.02 are true for solid coating SPME within thelinear range, then 
combination of eqs 2.18 and 2.01 or 2.02 gives the following equations.  






=−−=                 (2.30) 
[ ] [ ])exp(1)exp(1 0 atVKCatnn ffse −−=−−=                     (2.31) 
The above equations illustrate the linearly proportional relationship between 
n, the amount of analyte adsorbed on the coating before equilibrium was 
reached (t < te), and C0, the initial concentration of the analyte in the sample 
matrix.   
 
2.4.3 The Rate of Adsorption and Desorption  
The rate of adsorption and desorption can be judged by the value of the 
time constant, a, which is defined by eqs 2.11 and 2.12. Usually, Vs >>  KfsVf 
is always true because the number of the binding sites on the surface of the 
porous coating is much less than those in a liquid coating when the volume 
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of the two fibers is the same, assuming that the liquid coating fiber also has 
binding sites within. So the effect of sample volume on a value can be 
neglected. eq 2.12 can be taken as an accurate definition of the time constant 
a for a porous solid coating.   











                           (2.32) 
where, A/Vf is the surface area in a unit volume of fiber coating which is 
linearly proportional to the specific surface area for a given coating material, 
and describes the porosity of a porous solid coating. Temperature can affect 
Ds and K, thus a value, and the agitation will affect δs, the thickness of the 
boundary layer. In summary, the overall mass-transfer resistance (K/hs) is 
contained in the boundary layer for a given fiber. In another word, the 
agitation condition of the sample matrix can affect the rate for adsorption 
and desorption directly. So, calibration for the agitation effect during 
pre-equilibrium extraction is a must for quantitative analysis.    
Another point needs to note is that the distribution c nstant, K, in eq 
2.12 is not always the same as that in eqs 2.01, 2.2 30 and 2.31. The K in 
eq 2.12, defined by eq 2.6, is the real distribution c nstant, where Cs is the 
free concentration of the analyte in the boundary lyer, i.e., close to the free 
concentration of the analyte in the sample matrix. Therefore, the K value 
remains constant in different matrix for a given analyte and fiber coating. 
However, the distribution constant, Kfs, in Eqs. 2.01, 2.02, 2.30 and 2.31, 
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defined by Cf /Cs, is apparent distribution constant, where Cs can be either 
the free concentration or the total concentration in the standard solution. The 
value of Kfs changes in different matrices. So, both free concentration and 
total concentration can be obtained depending on what Kfs value is used.    
 
2.4.4 Kinetic calibration: Calibration of Adsorption by Desorption in 
Pre-equilibrium Extraction 
Similar to absorption-type SPME, the kinetic calibration method for 
solid coating SPME can be developed for calibration in pre-equilibrium 
extraction based on the symmetric relationship betwe n the adsorption and 
desorption.  
To determine the concentration of analyte in a sample matrix, the fiber 
was loaded with a known amount of isotopically labeed standard, q0. Then 
the preloaded fiber was exposed to the sample matrix for a short time period, 
t, during which an amount of the analytes were adsorbed onto the fiber 
surface while a part of labeled standard desorbed from the fiber to the 
sample matrix. According to eq 2.27, with the known loading amount of 
standard (q0), the remaining amount of standard (Q) and the extracted 
amount of analyte (n), the amount of analyte can be extracted from the 
sample in equilibrium (ne) can be calculated. Then, the initial sample 
concentration, C0, can be calculated using Eq. 2.02. Another approach is the 
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use of Eq. 2.26 or 2.29 to obtain the value of a, and then sample 
concentration can be calculated using eq 2.31.  
No matter which method is chosen, according to eq 2.02 or 2.31, 
another two parameters, the volume of the fiber, Vf, and the fiber 
coating/sample distribution coefficients of the analytes, Kfs, need to be 
known to calculate the sample concentrations, C0. Traditionally, scanning 
electron microscopy (SEM) is used to determine the thickness of the fiber 
coating, and then Vf can be calculated. However, this method is not only 
tedious but also not accurate for porous solid coating. A simple but efficient 
way to achieve the goal is the use of calibration curve to obtain the product 
of Vf and Kfs directly, as shown in Figure 2.4. A seven-point calibr tion (n = 
3, 5-1500 µg/L) was conducted. The regression slope presents the product of 
Vf and its Kfs. The standard solutions were prepared by spiking standards into 
the dog blood. Static extraction was performed until equilibrium reached (9 
min) at 37 ℃. Proper care was taken to keep the matrix and temperature the 
same to the real sample, and the extraction time was long enough to reach 
the equilibrium.  
But it needs to be noted that the application range of the 
aforementioned kinetic calibration is also limited in the linear range (5 - 
1000 µg/L) of the calibration curve, where 5µg/L is the limit of detection 
with the conditions we used, although the symmetry of the adsorption and 


























Figure 2.4. SPME calibration with PPY fibers for diazepam (♦) extraction. A 
seven-point calibration (n = 3), 5 to 1500 µg/L, was conducted.  
 
2.4.5 Application: Drug Analysis in Plasma and Whole Blood Sample 
In order to test the feasibility, the kinetic calibration method was used 
to quantify diazepam in clinical samples, plasma and whole blood with PPY 
fibers. 
The spiked diazepam in the plasma and whole blood matrix is 10 ppb 
(µg/L), 50 ppb, 200 ppb and 500 ppb. The extraction fr m plasma was 
conducted by agitation in a flow system with a linear velocity of 7.2 cm/s, 
while extraction from blood was conducted at static condition to avoid 
breaking of red blood cells by agitation.  
The product of Vf and Kfs for diazepam was determined from the 
regression slope of the calibration curve as shown in Figure 2.4, where the 
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standard solution was prepared by whole blood. Thus, t e total concentration 
of diazepam in whole blood can be calculated (based on the product of Vf 
and Kfs) from Figure 2.4. Similarly, the total concentration of diazepam in 
plasma can be calculated from spiked diazepam in plasma. In addition, the 
free concentration of diazepam in plasma and whole blood can be 
determined from the spiked diazepam in physiological saline solution. Here, 
the product of Vf and Kfs the distribution coefficient between fiber and 
physiological saline sloution, was determined to calcul te the concentration.    
 The relative recoveries and relative standard deviations (RSD) for 
diazepam in plasma and whole blood are summarized in Table 2.1. The 
results demonstrate the highly quantitative capability of the kinetic 
calibration method. This method would be very suitable for fast field and in 
vivo sampling with porous solid SPME fibers, where correctly performing 
the external calibration method for pre-equilibrium extraction is usually 









Table 2.1. Calculated relative recoveries of diazepam from plasma and 
whole blood sample at different concentrations with k netic calibration. 
 Relative recovery (%) (RSD, %; n = 6) 
Concentration (µg/L) Plasma sample Whole blood sample 
10 91.2 (13.6) 104.1 (12.8) 
50 93.3 (9.8) 107.2 (13.2) 
200 97.2 (11.9) 111.4 (16.9) 




2.5 CONCLUSION and ADDENDUM 
2.5.1 Conclusion 
In this chapter, the kinetics of adsorption and desorption for 
adsorption-type SPME coating based on a steady-state diffusion model is 
proposed. There are several important conclusions. Firstly, the mathematical 
expression of the adsorption kinetics provides a directly proportional 
relationship between the amount of analyte adsorbed on solid coating SPME 
fiber and its initial concentration in the sample matrix. This relationship 
suggests the potentiality of porous solid SPME fiber to be used for 
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quantitative analysis in pre-equilibrium extraction. Secondly, the kinetic 
calibration method was developed for accurate calibration in pre-equilibrium 
extraction using porous solid SPME fibers based on the symmetric 
relationship between adsorption and desorption. However, the quantification 
is limited within the linear range of the given fiber. In this study with whole 
blood, the detection limit of the method for diazepam is 5 ng/mL and linear 
up to 1000 ng/mL. In addition, the rate for adsorpti n and desorption is 
controlled by boundary layer, and the time constant was determined by the 
porosity of the fiber coating, the agitation, the matrix effect and the real 
distribution constant of the analyte between fiber coating and sample matrix. 
The fact of boundary layer controlled extraction furthe  points out the 
importance and necessity of the kinetic calibration t  compensate for the 
agitation and matrix effect during extraction with porous SPME fibers. The 
theoretical model is verified by the experimental dta, and a good agreement 
between them was observed. 
Finally, using PPY fibers, the developed kinetic calibr tion method was 
applied for drug analysis in clinical samples (plasm  and whole blood), and 
accurate results were obtained. 
2.5.2 Addendum 





Kinetic Calibration of Solid-Phase Microextraction for In 
Vivo Pharmacokinetic Studies  
3.1 Preamble and Introduction  
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Solid-phase microextraction (SPME) has gained extensiv  application 
and recognition in many areas since it was introduce  in 1990, 1-3 due to its 
unique advantages for rapid sampling. It integrates sampling, sample 
preparation, and sample introduction into one step, thus greatly simplifying 
the total process of chemical analysis. Moreover, as with limited extraction 
amount, it does not result in significant disturbance to the system under 
study. All the strengths indicate that SPME can be us d for in vivo sampling 
in a living system. However, in order to achieve accurately quantitative 
analysis, care must be taken for using appropriate c libration methods 
except meeting the demanding requirements for the in vivo use of the SPME 
probes.  
The first in vivo SPME was applied to pharmacokinetic studies, in 
which dog blood concentrations of benzodiazepines wre monitored during 
12 hours after injection of a dose of diazepam by using polypyrrole (PPY) 
fibers.4  External standard calibration method, also called calibration curve 
method, was used for quantification. The standard solutions were prepared 
by spiking benzodiazepine standards into commercial dog blood at known 
concentrations, and then in vitro extraction, solvent desorption, and 
instrumental analysis were conducted following the same procedure as for in 
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vivo SPME. The detected signals (the amount of analytes extracted from 
standard solutions) were plotted over the blood concentrations as calibration 
curves. Since the blood used to prepare standard solutions was not from the 
dogs in the in vivo SPME experiments, and the extraction conditions such as 
temperature between in vitro calibrations were not the same as in vivo 
SPME, the quantified results were more approximated.  
In order to address the inherent incapability of the calibration curve 
method, the kinetic calibration method,5,6 also called in-fiber standardization 
technique,7 was developed based on the symmetric relationship between the 
absorption process of analytes from sample matrix to the extraction phase 
and the desorption process of the preloaded standards from the extraction 
phase to the sample matrix; therefore, the extraction of analytes can be 
calibrated by determining the desorption of the pre-loaded standards (isotope 
labeled compounds are usually used as standards). This method is simpler 
than calibration curve method. And more importantly, it compensates the 
effect of agitation, temperature, and matrix, thus providing accurate 
quantification, especially for on-site sampling where standard addition and 
external standard calibration methods are not practicable. 5-11 Since in vivo 
sampling is a specific case of on-site sampling, kinetic calibration is 
presumably applicable for in vivo SPME if the appropriate SPME fiber is 
chosen for the given analytes. 
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In this report, the feasibility and the application conditions of the 
kinetic calibration for in vivo sampling by SPME are demonstrated. And the 
simplified one-point kinetic calibration and non-isotope labeled standard 
calibration method were developed based on the finding that the time 
constant, a, is independent from sample concentrations, which were well 
validated by the in vitro and in vivo SPME experiments. 
 
3.2 EXPERIMENTAL SECTION 
 
3.2.1 Preparation of SPME Probes 
PEG-C18 SPME probes and devices were prepared usingthe method 
described elsewhere.11 The C18 particles (10 micron) and PEG were donated 
by Supelco (Bellefonte, PA, USA) as a research sample. All fibers with the 
same capacity were selected out for in vivo experiments. The fibers with the 
same capacity were assumed to have the same volume, which was verified 
by finding that the extraction capacity is proportinal to the fiber volume by 
scanning electron microscopy.  
 
3.2.2 In vitro Experiments 
A systematic investigation was conducted on the extraction behaviors 
of the probes including extraction time profile, desorption time profile, 
matrix effect of plasma and whole blood, and dynamic range. By doing these 
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in vitro experiments, the experimental conditions were optimized for the in 
vivo experiments.  
All fibers used in the dog experiments were preloaded with deuterated 
standards.  The loading of standard on fibers was performed as follows: All 
the deuterated standards for diazepam, nordiazepam, and oxazepam were 
obtained from Cambridge Isotope Laboratories (Andover, MA, USA). The 
loading solution was prepared by spiking deuterated s andards (diazepam-d5, 
nordiazepam-d5, and oxazepam-d5) into 25 mL of sterile deionized-water at 
50 µg/L for each. Then the sterilized probes were exposed into the loading 
solution during 30 minutes for standard loading andthen kept in the sterile 
Falcon tubes for use.  
 
3.2.3 LC-MS/MS Analysis 
A CTC-PAL autosampler/Shimadzu 10 AVP LC/MDS Sciex API 3000 
tandem MS system was used for the analysis of the drugs and their 
deuterated standards. The assay conditions were the same as described 
before,4 except that the transitions monitored for the deuterated standards 
were: m/z 290.2/154.1 for diazepam-d5, 276.1/140.0 for nordiazepam-d5, 
and 292.1/246.1 for oxazepam-d5 respectively.  
 
3.2.4 Animal Experiments     
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All animal experiment procedures with beagles were approved by the 
Animal Care Committees at University of Guelph, and the experiments were 
performed in the Central Animal Facility of the University of Guelph 
(Guelph, ON, Canada) similarly as described previously 11 except the 
sterilization was conducted by immersing the samplers in 8 % formaldehyde 
and 70 % alcohol for 18 hours to avoid fiber damage during steam 
autoclaving.   
 
3.2.5 Conventional Blood Analysis  
In order to compare the SPME data with conventional blood assay, 1 
mL of blood was withdrawn after each SPME extraction and 2 mL of blood 
was withdrawn before diazepam injection for calibration. 4 Then 500 µL of 
acetonitrile was added to 100 µL of the whole blood in a 1.5-ml 
microcentrifuge tube, followed by vortex and centrifugation (5000 rpm, 10 
min). And then 400 µL of supernatant was taken out f r evaporation under 
nitrogen gas. Samples were reconstituted in 50 µL of reconstitute solution 
(methanol/pure water: 1/1, and containing 10 ppb of lorazepam as internal 
standard to calibrate the sample loss during instrumental analysis. The linear 
range was 5-2000 µg/L). A six-point calibration (n = 3) from 5-2000 µg/L 
for diazepam, nordiazepam, and oxazepam based on afrementioned 
approach was performed at 25 ℃. The standard solutions were prepared by 
spiking standards into the dog blood collected before drug administration. 
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3.3 RESULTS AND DISCUSSION  
The kinetic process for the absorption of analytes onto a SPME liquid 





−−=              (3.1) 
where n is the amount of analyte in the extraction phase after sampling time 
t, ne is the amount of analyte in the extraction phase at quilibrium, a is the 
time constant that is dependent on the volume of the extraction phase and 
sample, mass transfer coefficients, distribution coefficients, and the surface 
area of the extraction phase.  
The desorption of the preloaded standard from a SPME liquid coating 





Q −=                   (3.2) 
where Q is the amount of standard remaining in the extraction phase after 
exposure of the extraction phase to the sample matrix for the sampling time, 
t, and q0 is the amount of standard preloaded in the extraction phase. 
If the desorption and absorption processes occur under the same 
experimental conditions, the time constant  should be the same or similar 
for the same compounds or similar compounds. Thus te sum of Q/q0 (the 
fraction of the standard remaining on in the extraction phase after sampling 
time t) and n/ne (the fraction of the analyte absorbed into the extraction 
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phase after the same sampling time t) should be 1 at any 









                       (3.3) 
In eq 3, ne can be calculated easily since n, q0, and Q are detectable. 
Afterwards, the initial concentration of target analyte, C0, can be calculated 







=                 (3.4) 
where Vf and Vs are the volume of the fiber coating and the sample, 
respectively. Kfs is the fiber coating/sample distribution coefficient of the 
analyte. For on-site or in vivo sampling, since Vs >>  KfsVf, the concentration 
of target analyte can be calculated by the eq 3.5, which is the simplified 
form of eq 3.4,2  
ffse VKCn 0=                      (3.5)                         
The equilibrium SPME method based on eq 3.5 has been ext nsively applied 
to field sampling such as for air sampling13 and water sampling, 14 which is 
also the fundamental for in vivo sampling, because in these cases, the sample 
volume does not affect the results. 
The aforementioned derivation process indicates that t ere are two 
preconditions for on-site or in vivo kinetic calibration. One is the symmetric 
relationship between standard desorption and analyte bsorption described 
by eq 3.3, and another is the linear relationship between the amount of 
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analyte extracted in equilibrium ne and the initial concentration of target 
analyte C0, described by eqs 3.4 and 3.5. Therefore, the application 
conditions for on-site or in vivo kinetic calibration are determined: Firstly, 
the time constant a should be the same or nearly the same for the desorption 
and absorption, which means the physicochemical properties of the 
preloaded standard should be the same or very similar to the analyte. 
Usually the same compound or isotope labeled compound is preferable. 
Secondly, the experimental conditions such as matrix composition, agitation, 
temperature, and exposure time for the desorption pr cess should be the 
same or nearly the same to those in the absorption pr cess; therefore 
simultaneously conducting desorption and absorption is desirable. Thirdly, 
the kinetic calibration method only apply to the linear range of the SPME 
fiber in a given sample matrix. It is not applicable to those cases when the 
linear relationship between ne and sample concentration C0 was broken such 
as using adsorption-type SPME fibers in high sample concentration.15 Last 
but not least, during the time t, both the extracted amount  and desorbed 
amount q0 – Q should be reproducibly detectable, so n/ne or Q/q0 within the 
range of 40-60 % is preferable considering the undesirable variation from 
fiber making, experimental operation, and instrumental analysis. Thus 
pre-experimental determination of the appropriate smpling time for a given 
sampling system is needed before the in vivo experiments.  
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In order to verify the feasibility of the kinetic calibration for blood 
sampling, in vitro experiments were conducted to study the kinetics of the 
absorption and desorption of the deuterated and non-deuterated drugs in 
plasma over the linear range (10-2000 µg/L). First, PEG-C18 fibers 
preloaded with deuterated standard were exposed to a fl wing standard 
solution (flow rate 7.2 cm/s) prepared by spiking a fixed amount of 
diazepam, nordiazepam, and oxazepam in a given volume of plasma for 
different times to study the time profile for absorption and desorption. Then 
the relationship between the time constant  and drug concentrations in 
plasma was studied by varying the concentration of the standard solution. 
Figure 3.1 illustrates one of the absorption and desorption time profiles at 25 
oC (room temperature) with ln(Q/q0) or ln(1- n/ne) as y-axis, where the 
regression slope is – a based on eqs 3.1 and 3.2. For each drug analyte, there
is a good linear-relation between ln (Q/q0) or ln (1- n/ne) and time (R
2 > 
0.98), which demonstrates that eqs 3.1 and 3.2 accur tely describe the 
kinetics of SPME desorption and absorption based on PEG-C18 fibers for 
drug analysis. Figure 3.2 presents the values of Q/q0 calculated from the 
desorption time profiles and n/ne calculated from the absorption time 
profiles. The sum of Q/q0 and n/ne is close to 1 at each point (the results 
range is 0.97-1.15), which demonstrates the symmetry of the absorption and 
desorption. The averaged value of the sum of Q/q0 and n/ne is 1.07, 
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somewhat higher than 1 due to the little difference of physicochemical 
properties between a drug analyte and its deuterated analogue.  
    Moreover, the equilibration time, te (t95%  ≈ 5-9 min for the three 
analytes), and the amount of analyte extracted at equilibrium, ne, can also be 
obtained from the absorption/desorption time profiles. It is found that both te 
(t95%) and ne of the extraction based on PEG-C18 fibers is roughly two-folds 
of PPY fibers in plasma matrix at the concentration of 50 µg/L, which 
suggested PEG-C18 fibers are more suitable for pre-equilibrium sampling 
than PPY fibers because both fast extraction time and high sensitivity can be 
compromised, while it is impossible for PPY fibers. And the sampling time 
for in vivo experiment was set for 2 min so as to keep the n/ne and Q/q0 
within the range of 40-60 %. 
The values of the time constant a calculated from each absorption and 
desorption time profile in plasma samples at different concentrations are 
listed in table 3.1. The data show that the value of time constant a for 
absorption of benzodiazepines in plasma is close to that for desorption of 
their deuterated analogues, which suggests that the deuterated standards in 
this work were suitable for the kinetic calibration. However, it should be 
noted that the isotope labeled standard can be used for the kinetic calibration 
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Figure 3.1. The desorption time profiles (A) of diazepam-d5 (◊), nordiazepam-d5 
(□), and oxazepam-d5 (∆) and absorption time profiles (B) of diazepam (◊), 
nordiazepam (□), and oxazepam (∆). The absorption and desorption were 

























Figure 3.2. The absorption and desorption time profiles for of diazepam (◊), 
nordiazepam (□), and oxazepam (∆) and their deuterated analogues: diazepam-d5 




In order to calculate the sample concentrations, C0, another two 
parameters, the volume of the fiber, Vf, and the fiber coating/sample 
distribution coefficients of the analytes, Kfs, need to be determined in eq 3.5. 
Traditionally, scanning electron microscopy (SEM) is used to determine the 
thickness of the fiber coating and then Vf can be calculated.
17 However, this 
method is not just tedious but also not accurate. Here we reported a very 
simple but efficient way to achieve the goal, i.e., using calibration curves to 
obtain the product of Vf and Kfs directly, as shown in Figure 3.3. The 
standard solutions were prepared by spiking standards into the dog blood 
obtained from the same beagles for in vivo SPME experiments. Static 
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equilibrium-extraction was performed because agitation doesn’t affect Vf 
and Kfs, but temperature should be the same as in vivo SPME because 
temperature affects Kfs. In Figure 4, the regression slope of each trend line is 
the product of Vf and Kfs for the corresponding analyte according to eq 5, 
where Kfs is the fiber coating/blood sample distribution coefficients of the 
drugs. Actually we do not need to calculate or determine Vf and Kfs 
separately; instead we only need the product of Vf and Kfs to calculate the 
sample concentration, C0, by using eq 3.5. What deserves mention here is 
that calibration curves were used for finding out Vf  × Kfs rather than 
calibrating the in vivo SPME, where the effect from agitation on the 
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Figure 3.3. SPME calibration with PEG-C18 fibers for diazepam (◊), nordiazepam 
(□), and oxazepam (∆). A six-point calibration (n = 3) from 0.5-1000 µg/L was 
conducted. The regression slope for each analyte presents the product of Vf and its 
Kfs. The standard solutions were prepared by spiking standards into the dog blood 
obtained from the same beagles for the in vivo SPME experiments before drug 
injection. Static extraction was performed until equilibrium reached (10min) at 37 
℃. The detection limit of the method is shown as 0.5µg/L. 
 
Using the values of Vf  × Kfs with Figure 3.3, the sample concentration, 
C0, calculated by eq 3.5, is the total concentration of the drug in whole 
blood, since the Kfs used here is distribution coefficient of the drug between 
the fiber coating and blood matrix. And the free fraction of the drug, which 
is the active portion of the dose in blood, can be o tained by using the 
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distribution coefficients of the drugs between fiber and buffer instead. The 
product of Vf  × Kfs for fiber/buffer can be obtained using the calibration 
curve method in which the standard solutions are prepared with drugs spiked 
phosphate buffered saline (pH 7.4). Actually, this method for obtaining the 
product of Vf  × Kfs from calibration curve can apply  to determining the 
total and free concentrations in any sample matrix as long as the standard 
solutions with the same sample matrix. With this method, the binding 
affinity of the drugs to blood matrix can be calculated by using a similar way 
described elsewhere. 18 
y = 0.0203x + 0.2594
R2 = 0.9983
y = 0.0248x + 0.4606
R2 = 0.9995





















Figure 3.4. Calibration for the conventional blood analysis. A six-point calibration 
(n = 3) from 5-2000 µg/L for diazepam (◊), nordiazepam (□), and oxazepam (∆) 
based on chemical assay was performed at 25 ℃. The standard solutions were 
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prepared by spiking standards into the dog blood obtained from the same beagles 
for the in vivo SPME experiments before drug injection. The detection limit of the 
method is 5µg/L.  
 
In previous studies, the conventional blood draw followed by plasma 
preparation, and chemical analysis was conducted to obtain the total 
concentration of drugs in plasma. And the resulting plasma concentrations 
were used to validate the blood concentrations by SPME without 
considering the absorption of the drugs by blood cells.4, 11 In this research, 
the partitioning of the drug analytes between blood cells and plasma was 
determined. The percentages of the three analytes diazepam, nordiazepam, 
and oxazepam partitioned in the plasma are about 59 %, 63 %, and 68 %, 
respectively, where the drug concentrations in whole blood were taken as 
100 %. Consequently, the total concentrations obtained from conventional 
chemical analysis were used to validate the total concentrations from SPME 
experiments. The procedure of the chemical assay is described in the 
experimental section, and calibration curves, as shown in Figure 3.4, were 
employed to calibrate the concentrations in blood. The linear correlation 
coefficients (R2) are better than 0.998, which demonstrates the validity of the 
































Figure 3.5. Averaged pharmacokinetic profiles of diazepam, nordiazepam, and 
oxazepam  were monitored by in vivo SPME over 8 hours on three dogs (n = 6 for 
the last point, and n = 9 for all the other points). Kinetic calibration based on 
deuterated standards was performed during the experimental course.   
 
For in vivo SPME experiments, diazepam pharmacokinetics in dogs 
was studied to evaluate the performance of PEG-C18 probes and the kinetic 
calibration method. The pharmacokinetic profiles of diazepam and the two 
significant metabolites nordiazepam and oxazepam were monitored by in 
vivo SPME over 8 hours, as shown in Figure 3.5. Accordingly, the results of 
conventional blood analysis were presented in Figure 3.6. The results from 
in vivo SPME showed good consistence with the results from c nventional 
assay. The correlation coefficients (r) between them are close to 1 (0.97- 
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0.99). The results showed that the metabolism rate for diazepam in beagles 
was rapid, as evidenced by the fact that nordiazepam had higher 
concentrations even in the early stage after drug administration. 
Compared to the previous studies,4, 11 this work provides more detailed 
and accurate information in the pharmacokinetic profiles ascribed to 
combining the following advantages together: the accuracy and high 
sensitivity resulted from the large linear range and high capacity of 
non-competitive PEG-C18 probes, the fast extraction time decided by 
pre-equilibrium extraction, as well as the proved merit that the kinetic 
calibration is inherently more accurate than calibrtion curve method.  
 
3.4 CONCLUSION and ADDENDUM 
 
3.4.1 Conclusion 
In this work, the feasibility of the kinetic calibration of SPME for in 
vivo sampling was demonstrated by theoretical considerations and 
experimental verification. And the application conditions of this method 
deserve more attention. Up to now, all the applications of kinetic calibration 
are restricted in liquid coating SPME, while further investigation for solid 
coating need to conduct in future. As a result, firstly, the nature of the SPME 
fiber coating must be determined before using; secondly, the linear range, 
capacity, equilibration time of the extraction in a given sample matrix need 
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to be determined to decide the appropriate sampling time so as to keep the 
n/ne and Q/q0 within the range of 40-60 %.  
In order to obtain the concentration, a simple method was proposed to 
calculate the product of Vf and Kfs, instead of using the traditional Scanning 
Electron Microscopy method, which is more tedious and more expensive. 
Therefore, either the total drug concentration or free concentration can be 
obtained by using Kfs for fiber/blood (or other matrix) or fiber/ buffer 
respectively. The developed method is sensitive for blood sampling 
(detection limit: 0.5 ng/mL) and broad linear range (0.5-1000 ng/mL). 
Finally, the PEG-C18 fibers were applied to the in vivo sampling, more 
detailed information in the pharmacokinetic profiles were obtained because 
of the larger linear range and higher capacity of PEG-C18 probes, as well as 
the faster extraction time. In addition, a simple chemical assay was 
developed to determine the total concentrations of drugs in whole blood 
(detection limit: 5 ng/mL; linear range 5-2000 ng/mL), and the results were 




































Figure 3.6. Averaged pharmacokinetic profiles of diazepam, nordiazepam, and 
oxazepam were monitored by conventional blood draws and in vitro chemical assay 
over 8 hours on three dogs (n = 3). Calibration was based on standard curves 
shown in Figure 3.4. 
 
3.4.2 Addendum 





Simplified Kinetic Calibration of Solid-Phase 
Microextraction for In Vivo Dynamic Monitoring 
 
4.1 Preamble and Introduction   
4.1.1 Preamble 
This chapter has not been published. Ali Es-haghi nd Jibao Cai contributed 
to this project. The contributions of Es-haghi, A. involved the in vivo 
experiment. And Cai, J. contributed to the in vitro microdialysis experiment 
and manuscript revision.  
I, Ali Es-haghi, authorize Xu Zhang to use the materi l for his thesis. 
Signature: 
 









Solid-phase microextraction (SPME) has been demonstrated to be a 
promising approach to in vivo sampling for pharmacokinetic studies, due to 
its simple instrumentation and implementation, its t me-effectiveness and 
cost-effectiveness, its miniaturized format, and the little disturbance it 
causes to the system under study. 1-4 However, improving the quantitative 
capability and automatic potential of SPME for in vivo application remains 
the main task for further development. These improvements can be 
addressed significantly by bettering the calibration method, because the 
operational procedure is mainly determined by the calibration approach 
adopted. On one hand, the simpler the operation, the easier the automation 
of the procedure; on the other hand, the accuracy of SPME approach, as a 
distribution equilibrium based sampling technique, d pends on whether the 
appropriate calibration procedure is adopted. Moreover, it would be 
desirable to have an analytical method with high temporal resolution for 
dynamic monitoring in a living system, as in vivo pharmacokinetic studies. 
Therefore, fast sampling based on pre-equilibrium SPME would be more 
suitable than the widely-used sampling strategy based on equilibrium 
extraction. However, the well-established external calibration method is not 
suitable to in vivo pre-equilibrium sampling due to its inability of correcting 
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for unknown blood flow, which can seriously affect SPME results in 
pre-equilibrium conditions.  
Accordingly, quantitative analysis was conducted by adopting the 
kinetic calibration method, or standard-on-fiber calibr tion, by which 
analyte extraction is calibrated by determining the d sorption of the 
pre-loaded standards on the fiber. 5-6 Normally, isotope-labeled analogues of 
the analyte compounds are used as standards and a mass spectrometer serves 
as the detector. This method is not only simpler than the calibration curve 
method, but also compensates for the effects of agitation, temperature, and 
matrix, and thus provides accurate quantification, especially for on-site 
sampling where the traditional standard addition calibr tion is not 
applicable. 7-10 However, the classic kinetic calibration is based on the use of 
often expensive or even unavailable isotopically labe ed standards; this 
restricts the method from widely application. In addition, at every sampling 
time-point during the whole experiment fiber with preloaded-standard is 
needed even in the same sample system, which not only increases the cost, 
but may also cause experimental error. For example, there must be some loss 
of standard and/or its activity within the standard-p eloaded fibers, since all 
the fibers are loaded simultaneously but not used at the same time. The loss 
could be significant when using volatile compounds a  standards or 
radioisotope-labeled standards with short half-lives. Finally, the mass 
spectrometer (MS) must be required to differentiate th  analytes and 
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deuterated standards, thus not suitable for on-site monitoring for field 
sampling; moreover, the MS instrument might not be available in every lab 
and institution, especially in developing countries due to its high price.  
There have been some efforts to address this problem. Recently a 
dominant kinetic calibration method was proposed in which the normal 
standard instead of the deuterated standard is employed as the calibrant.11 
But the method is inherently limited because the extracted analyte affects 
quantification of the detected standard signal and results in systematic 
errors. To reduce error, it is thus necessary that t e amount of extracted 
analyte is negligible compared to the amount of standard remaining on the 
fiber after desorption. Accordingly, the sampling time must be very short; 
however, a short sampling time decreases the method’s sensitivity and 
makes it inapplicable for low concentration samples. When sample 
concentration is high, systematic error from the int rference of the signals of 
analytes with those of standards can be significant. I  addition, the 
experimental operation is time-consuming and labor-intensive because it 
uses four fibers for standard desorption and an additional fiber for sampling 
in different sampling sites—which may further decreas  the accuracyof the 
SPME analysis by overlooking variation in concentration among sampling 
sites. The technique may be useful for studying a static and uniform sample 
system, but it is not suitable for highly dynamic systems, as in 
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pharmacokinetic studies of veins where blood flows and drug concentrations 
change quickly due to a fast metabolism rate.  
In this report, based on the finding that the time constant a is 
independent from sample concentrations, a single time-point kinetic 
calibration was proposed. Afterwards, a normal standard 
(non-isotope-labeled) kinetic calibration was develop d when applying the 
single time-point calibration before the drug was dosed into the living 
system. Furthermore, the use of single-standard to accurately calibrate 
multiple analytes was brought forward, and the quantitative relationship 
between different analyte concentrations was derived. Finally, a single-point 
self-calibrated SPME approach was developed for in vivo pharmacokinetic 
studies. Based on these simplified calibrations, the in vivo SPME approach 
for pharmacokinetic studies can be operationally simple, cheap, but more 
accurate. 
To clarify, a brief comparison of two groups of terms is given as 
follows. First, sampling time-point (also called time-point for sampling or 
simply time-point) describes the specific instances during the whole 
pharmacokinetic course when SPME sampling is performed. For example, 
in the current study, the whole pharmacokinetic course was 8 hours, and 
there were 9 sampling time-points: 5 min, 0.5 h, 1 .5 h, 2 h, 3 h, 4 h, 6h, 
8h. By contrast, the term “sampling time” describes the length of time the 
SPME fiber is in direct contact with the target sample.  For example, in the 
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current in vivo study, sampling times were set at 2 min and 1 min; the 
sampling time started after the sampler was introduce  into sample and the 
SPME fiber was exposed to venous blood, and stopped when the fiber was 
withdrawn from the vein.  
Second, for SPME experiments, there are usually twoypes of 
calibration. One is calibration for the instrument response. For example, 
when using HPLC-MS/MS as a detector, an external calibration curve must 
be constructed in order to calibrate the response factors (the process relating 
the amount of analyte introduced into the instrument with its response). The 
second is calibration for the sampling approach or the SPME method, the 
process relating the amount of analyte extracted by the SPME fiber with the 
initial analyte concentration in the sample. This study focused on calibration 
of the SPME for in vivo dynamic monitoring, where whether it is necessary 
to use chemical standards for quantification depends on the calibration 
method adopted. However, the standards must be usedto calibrate the 
instrument response.   
 
4.2 EXPERIMENTAL SECTION 
 
4.2.1 Preparation of SPME Probes  
PEG-C18 SPME probes and devices that were prepared by the method 
were described elsewhere.3 The C18 particles (10 micron) and PEG were 
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from Supelco (Bellefonte, PA). The home-made fibers were with quite large 
inter-fiber variation (up to 70-80%) in terms of the amount of analyte 
extracted at equilibrium; therefore, all fibers that d the same capacity were 
selected for in vivo experiments.  
 
4.2.2 In vitro Experiments 
The extraction behaviors of the probes including extraction time 
profile, desorption time profile, matrix effect of plasma and whole blood, 
and dynamic range were characterized in previous work. In this project, to 
test the feasibility of the simplified calibration methods under a precisely 
controllable condition, all in vitro experiments were conducted within a 
simple artificial circulation system, which was designed to simulate the 
blood flow in dog’s vein and the schematic was repoted in previous report.4 
Phosphate buffered saline (PBS, pH 7.4) and EDTA-anticoagulated beagle 
whole blood and plasma from Biological Specialties Corp. (Colmar, PA) 
were used as sample matrix and flowed within the artificial circulation 
system and the flow rate was set by the peristaltic pumps.  
The deuterated standards (diazepam-d5, nordiazepam-d5, and 
oxazepam-d5) were from Cambridge Isotope Laboratories (Andover, MA) 
and the non-deuterated standards (diazepam, nordiazepam, and oxazepam) 
were from Cerilliant (Austin, TX). For loading the fibers with standards for 
calibration, the loading solution was prepared by spiking deuterated 
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standards or non-deuterated standards into deionized-water at 50 µg/L for 
each. For in vivo use, the fibers should be sterilized by immersing the
samplers in 8 % formaldehyde and 70 % ethanol for 18 hours. Then the 
sterilized probes were exposed into the loading solution during 30 minutes 
for loading and then kept in the sterile Falcon tubes for use. For in vitro 
experiments, the fibers and the deionized-water were not sterilized; the other 
conditions were the same. 
 
4.2.3 LC-MS/MS Analysis 
A CTC-PAL autosampler/Shimadzu 10 AVP LC/MDS Sciex API 3000 
tandem MS system was used for the analysis of the drugs and their 
deuterated standards. The assay conditions were the same as described 
before,1,3 except that the transitions monitored for the deuterated standards 
were: m/z 290.2/154.1 for diazepam-d5, 276.1/140.0 for nordiazepam-d5, 
and 292.1/246.1 for oxazepam-d5 respectively.  
 
4.2.4 Animal Experiments     
All animal experiment procedures were approved by the Animal Care 
Committees at University of Guelph, and the experimnts were performed in 
the Central Animal Facility of the University of Guelph (Guelph, ON, 
Canada) as described previously. 3 The dosage of diazepam was 0.5 mg/kg. 
About 20 minutes before the intravenous administration of diazepam, three 
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sequential desorption experiments were conducted by consecutively 
introducing three probes that were preloaded with non-deuterated diazepam 
into the cephalic vein through the implanted catheter. The desorption lasted 
2 min, and then after a brief rinse with deionized water and drying with 
Chemwipes, the probes were withdrawn and kept in sterile tubes in dry ice 
for lab analysis. Blood concentrations of diazepam, nordiazepam and 
oxazepam were monitored for 8 h. At each sampling time-point, one probe 
loaded with deuterated standard was introduced for 2 min to perform 
pre-equilibrium extraction after blood drawing for conventional analysis. At 
the 2 h and 3 h time points, two blank probes (withou  standard) were 
introduced sequentially before the introduction of the probe with deuterated 
standards. The sampling time is 1 min and 2 min for the two blank probes, 
respectively. Therefore, at each of these two sampling time-points, three 
probes were employed, the first two of which were blank probes and the last 
one was preloaded with deuterated standards.  
 
4.2.5 Conventional Blood Analysis  
The conventional blood assay was conducted as previously described.3 
One mL of blood was withdrawn after SPME extraction at each time-point, 
and 2 mL of blood was withdrawn before the three diazepam-loaded fibers 
were introduced. Five hundred µL of acetonitrile were mixed with 100 µL of 
whole blood in a 1.5-ml microcentrifuge tube, followed by vortex and 
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centrifugation (5000 rpm, 10 min). Then 400 µL of supernatant were 
collected and evaporated under nitrogen gas. Samples were reconstituted in 
50 µL of reconstitute solution (methanol/pure water: 1/1, containing 10µg/L 
of lorazepam as an internal standard). A six-point calibration (n = 3) from 
5-2000 µg/L for diazepam, nordiazepam, and oxazepam w s performed at 
25 ℃. The standard solutions were prepared by spiking standards into the 
dog blood collected before drug administration. 
 
4.3 RESULTS AND DISCUSSION  
A unique advantage of the SPME technique is its efficacy and simple 
implementation in on-site sampling, of which in vivo sampling is a specific 
case where sample concentrations change quickly and the matrix effect is 
complicated. It requires not only sampling probes with fast response times, 
but also appropriate calibration methods. However, the traditional standard 
addition method and internal standard method are not applicable for in vivo 
sampling because it is impossible to handle the sample—for example, to mix 
the sample with spiked standards very well and to prevent metabolic 
degradation of the standards. The well-established calibration curve method 
can deliver accurate results for on-site or in vivo SPME, but only when 
equilibrium extraction is performed.  Only kinetic calibration using a 
preloaded standard on the fiber can achieve accurate c libration for 
pre-equilibrium sampling.5 When kinetic calibration is applied in i  vivo 
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sampling, it is interesting to find that, Q (the amount of preloaded standard 
remaining on the fiber after 2-min sampling) was almost constant at 
different sampling time-points (Fig. 4.1). This find g suggested that we can 
further simplify the kinetic calibration without sacrificing its precision and 
accuracy. After careful investigation of desorption and extraction processes, 
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Figure 4.1. The amount of deuterated standard remaining in the fibers (Q) after 
exposure of the preloaded fibers in vein for 2 min at each time point for SPME 
sampling during the 8-hour in vivo experiment. 
 
 
4.3.1 One-Point Kinetic Calibration for Pharmacokinetic Studies     
The classic kinetic calibration is based on the symmetric relationship 
between absorption (or adsorption) of analytes onto the fiber and the 
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                       (4.01) 
where n is the amount of analyte in the extraction phase after sampling time 
t, ne is the amount of analyte in the extraction phase at equilibrium, Q is the 
amount of standard remaining in the extraction phase after exposure of the 
extraction phase to the sample matrix for the sampling time, t, and q0 is the 
amount of standard preloaded in the extraction phase. 
In the in vivo pharmacokinetic studies, we observed that Q was a 
constant at every time point (from 5 min to 8 h) after the fiber was exposed 
into the venous blood for 2 min (t, sampling time). If it is true through the 
duration of 8-hour experiment, 1 - Q/q0 should also be a constant, since q0 
was a constant, which was set when the fibers were sel cted out. 
Consequently, n/ne is a constant according to eq 4.01. Thus the purpose of 
the calibration is to find the constant value of n/ne or 1 - Q/q0 . As Q is a 
constant at every sampling time-point, one time-point is enough to find the 
Q value instead of conducting the standard desorption at all the time-points. 
The only benefit for conducting standard desorption at multiple time-points 
is decreasing the standard deviation by increased repetition times. However, 
we could achieve this by repeating desorption several times at one single 
time-point rather than multiple time-points. Therefor  the assumption that Q 
is a constant during the pharmacokinetic studies provides the basis for the 
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simplification of the classic kinetic calibration to single time-point 
calibration. 
In order to verify this basic assumption, both theoretical and 
experimental studies were conducted. In theory, it is easy to find that only 
sampling time, t, and the time constant, a affect the Q value according to the 





Q −=                   (4.02) 
 In the experiment, t is always 2 min for all the fibers. Therefore, Q 
would be a constant as long as  value keeps constant. For diffusion in 
boundary layer based SPME using C18-PEG fibers, a value is dependent on 
fiber parameters, the fiber-sample distribution coeffici nt, and the sample 







=                     (4.03) 
where Ds is the diffusion coefficient of the analyte molecules in the sample 
matrix, δs is the thickness of the boundary layer, which is mainly affected by 
the agitation,12 Kfs is the distribution coefficient of the analyte betw en fiber 
coating and sample matrix, A is the surface area of the fiber coating, Vf is the 
fiber volume; for an adsorptive coating, the quotient of A/Vf  is the specific 
surface area of the fiber coating, which describes th  porosity of the coating 
material. The eq 4.03 indicates that in the same sampling system, where all 
the conditions such as the analyte, fibers, sample atrix, temperature and 
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agitation are fixed, a value should keep constant, and thus makes Q value 
constant. It is easy to be understood that, in the beagle experiment, the 
physiological conditions of the dogs such as the temp rature, flow rate and 
composition of the venous blood did not fluctuate too much to create 
significant variation of a value and Q. The data from the in vivo experiment 
support the single-point calibration. For example, as shown in Fig 2, the 
averaged Q value of oxazepam-d5 (16 ± 1 pg, n = 3) at the time-point of 1.5 
hour after drug administration was used to calibrate the sampling at all the 9 
time-points. The results were very consistent with those from the 
conventional multiple time-point calibration.  
The single-point kinetic calibration would be more timesaving and 
cost-effective since it uses much less standards an standard loaded fibers. 
Meanwhile, there would be no error from the loss of standard and/or its 
activity (e.g., radioactivity) in the fibers since all the fibers are not only 
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Figure 4.2. The blood concentrations of oxazepam calibrated by single time-point 
kinetic calibration and by multiple time-point calibration. The single time-point 
calibration was based on the desorption of oxazepam-d5 at the time-point of 1.5 
hour after drug administration. 
 
In addition, the observation that Q value kept constant during the 
8-hour indicated that a value was not affected by sample concentration, 
which changes dramatically during the pharmacokinetic profile. Actually, in 
eq 4.03 there is not a factor determined by the analyte concentration as long 
as the concentration does not change so much that it affects the sample 
composition significantly. In order to verify this argument, an in vitro 
experiment was conducted to test the relationship between a value and 
sample concentration. Standard solutions were prepared in dog plasma with 
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different concentrations from low concentration 10 ng/ml to high 
concentration 2000 ng/ml. The standard solutions circulated in the flow 
system at a linear velocity of 7.2 cm/s (at 25 ˚C). The SPME fibers loaded 
with deuterated standards were exposed into the standard solutions in 
different time to obtain desorption and extraction time profiles. The values 
of the a constant could be easily obtained from the slopes of the logarithmic 
form of extraction/desorption time profiles (Fig 4.3); Table 4.1 presented a 
values that were calculate by using (1/t)ln[ne/(ne-n)] with extraction data or 
(1/t)ln(q0/Q) with desorption data. The data confirm that the a value is 
independent of the sample concentrations. This conclusion is also consistent 
with the observation that the sample concentration has no impact on the 












Table 4.1. Time constant a for absorption and desorption of 
benzodiazepines in plasma samples at different concentrations 
 
 time constant a (SD) 
absorption (25 ℃) C0 (µg/L) diazepam nordiazepam oxazepam 
 10 0.3498 (0.0321) 0.3338 (0.0232) 0.5791 (0.3241) 
 50 0.3611 (0.0343) 0.3404 (0.03105) 0.5823 (0.4322) 
 500 0.3551 (0.0239) 0.3329 (0.0347) 0.5945 (0.0512) 
 2000 0.3429 (0.0312) 0.3358 (0.0344) 0.601 (0.0459) 
desorption (25 ℃)  diazepam (d5) nordiazepam (d5) oxazepam (d5) 
 10 0.3532 (0.0328) 0.3576 (0.3124) 0.5878 (0.0602) 
 50 0.3681 (0.0396) 0.3697 (0.0421) 0.5714 (0.0475) 
 500 0.354 (0.0402) 0.3236 (0.0332) 0.6005 (0.0575) 
 2000 0.3601 (0.0399) 0.3427 (0.0198) 0.6167 (0.0626) 
 
 
This finding has two important implications. Firstly, if the absorption 
(for extraction) or desorption (for calibration) isoptimized for a given 
concentration, the equilibrium time and the time constant a will be the same 
for other concentrations. This proves the feasibility of SPME for dynamic 
monitoring. Secondly, as mentioned before, in dynamic onitoring like a 
pharmacokinetic study, the information of the desorpti n obtained from any 
single time-point can be used to calibrate the data for absorption from all 
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other sampling time-points through the whole experim ntal duration, as long 
as the experimental conditions such as sample matrix, agitation, and 
temperature do not change significantly over the experiment course. This 
provides the basis for simplifying the multiple time-point kinetic calibration 
to a single time-point calibration. 
However, for practical use of the single-point kinet c calibration, three 
experimental issues deserve further discussion. The first is how many times 
repetitive desorption should be conducted at the single time-point in order to 
ensure the method’s precision. According to statistical principles, the 
standard error will not be improved rapidly after 3 - 4 replicates.14 Therefore 
we chose three-time repetition in this study.  
The second issue is the length of the sampling time(also desorption 
time). As an analytical method with high quantitative capability, the single 
time-point SPME strategy should be highly accurate nd precise. This 
requires a relatively long sampling time, so that the difference between Q, 
the remaining amount of standard on the fiber, and q0, the amount of 
standard preloaded on the fiber, is significant. Thus the longer the sampling 
time, the more accurate the results—but also the worse the temporal 
resolution of the sampling for tracking drug metabolism in a dynamic 
monitoring situation where sample concentrations change rapidly. To 
compromise between temporal resolution and accuracy, both the extracted 
amount (n) and desorbed amount (q0 – Q) should be reproducibly detectable; 
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therefore, a n/ne or Q/q0 within the 30-70% range is preferable, considering 
the undesirable variation in fiber manufacturing, experimental operation, and 
instrumental analysis. The in vitro experiment showed that 2-min was good 
for both desorption and extraction. 
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Figure 4.3. The desorption time profiles (A) of diazepam-d5 (◊), nordiazepam-d5 (□), 






(□), and oxazepam (∆). The absorption and desorption were performed in plasma 
standard solution in a flow system at a rate of 7.2 cm/s (at 25 ˚C). 
 
The last issue is determining which time-point during the whole 
pharmacokinetic duration should be selected for the standard desorption. 
Theoretically, as long as the blood flow (agitation f the sample) does not 
change significantly, all time-points can be chosen for the standard 
desorption. However, in practice, time-points at a sufficient time interval 
from the next sampling is preferable, in order to ensure enough time for 
performing several sequential desorption experiments; this is because it is 
not practical to conduct parallel operations, given the dimension of dog’s 
forearm vein. In this pharmacokinetic study, flowing time-points, such as 2h, 
3h, 4 h, 6h and 8 h, are preferable because the 1-2 hour interval is enough 
for performing the standard desorption in all three dogs.  
 
4.3.2 One-Point Kinetic Calibration by Non-isotope Labeled Standard  
Interestingly, performing the standard desorption before drug 
administration brought a more important simplificaton of the kinetic 
calibration. As discussed above, the Q value will remain constant as long as 
blood flow does not change significantly. This indicates the possibility of 
performing the desorption with the non-isotope labeled standards (i.e., the 
normal standards for the analytes) in order to obtain Q before drug 
administration, when there is no endogenous source (f om metabolism or 
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secretion) of drug analyte in the blood to interfere the Q value. This new 
approach might be called “non-isotope labeled standard kinetic calibration”. 
Theoretically this approach is more accurate than using isotope-labeled 
compounds as standards, because there is no difference in the 
physicochemical properties between the analyte and the standard (i.e., they 
are the same), and because the sum of Q/q0 and n/ne is exactly 1. By contrast, 
the difference between the isotope-labeled standards n  their non-labeled 
counterparts affects the accuracy of the calibration. For example, in previous 
studies, the sum of Q/q0 and n/ne was always somewhat different from 1.
5,8-9 
Moreover, when the isotope-labeled compounds are not available, the 
kinetic calibration based on  non-labeled standards is the only option. 
Furthermore, it is cost-effective since isotopic labeled standards are usually 
much more expensive than non-labeled ones.  
This novel calibration method was verified by the in vivo experiment. 
Before the drugs were administrated, the PEG-C18 fibers, which were 
preloaded with non-deuterated diazepam/nordiazepam/oxazepam standards, 
were introduced into the venous blood for 2 min. There is no significant 
difference between the resulting Q values with non-labeled standards 
(Diazepam: 54 ± 5 pg; nordiazepam: 57 ± 6 pg; oxazep m: 17 ± 3 pg, n = 6) 
and those obtained with using deuterated standards.  
 
4.3.3 Single Standard Kinetic Calibration for Multiple Analytes  
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In pharmacokinetic studies, the concentrations of both the dosed drug 
and its metabolites need to be monitored simultaneously. More analytes are 
addressed in some environmental screening studies.15-17 In all cases for 
quantitative analysis of multiple analytes, it would be desirable to use a 
single standard to calibrate all analytes simultaneously. However, there were 
significant discrepancies between the true concentrations and the calibrated 
ones when using classic kinetic calibration.5  
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where a1 and as are the time constant for the analyte and the preloaded 
standard respectively. When the exposure time, t, is fixed, the sum of Q/q0 
and n/ne is a constant, b. Since n, q0, and Q are detectable, ne can be 







=                               (4.05) 
Afterwards, the initial sample concentration, C0 can be calculated 
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Furthermore, the concentration ratio of any two analytes can be 

































                      (4.07) 
where Kfs1 and Kfs2 are the fiber coating/sample distribution coefficients of 
target analyte 1 and 2 respectively; n1 and n2 are the extraction amount of 
target analyte 1 and 2 respectively; and C1  and C2 are the sample 
concentrations of target analyte 1 and 2.  
Eq 4.07 is suitable for pre-equilibrium sampling. By substituting eq 
4.04 into eq 4.07, when Vs >> KfsVf, the concentration ratio of two analytes 










C =                              (4.08) 
where ne1 and ne2 are the amount of two analyte that can be extracted in 
equilibrium.  
The values of a1 and a2 can be obtained by doing desorption experiment 
once or absorption experiment twice in standard solutions. In the in vivo 
sampling, a values for diazepam, nordiazepam, and oxazepam are 0.7, 0.65, 
and 1.1 min-1 respectively. Actually, when two a values of two analyes are 
not very different, such as those for diazepam and nor iazepam, eq 4.08 can 
be directly used to calculate the concentrations of nordiazepam by using 
those of diazepam. The ratio of Ke2 / Kfs1 can be obtained by comparing the 
slopes of the two calibration curves in the same standard solution with 
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equilibrium extraction.3 In the cases when PDMS fibers are employed for 
aqueous samples, the ratio can be estimated with their Kow values. 
18-20 
With these equations (eq 4.06-4.08), the concentrations of other 
analytes can be calculated when the concentration of any one analyte is 
obtained. Furthermore, with eq 4.07, the quantitative relationship of the 
concentrations between different analytes was establi hed.  As a result, the 
one standard kinetic calibration method was developed. 
An in vitro experiment was conducted to verify the theory. From the 
natural logarithm format of the absorption time profiles in PBS in the flow 
system at 6.5 cm/s (at 25 ˚C), we calculated the a values for the three 
analytes and deuterated standard (a = 0.27, 0.25, 0.48, and 0.26 for 
diazepam, nordiazepam, and oxazepam, and diazepam-d5 respectively). 
Afterwards, we used the desorption of diazepam-d5 to calibrate the 
absorption of diazepam, nordiazepam, and oxazepam. The sample 
concentrations are from low to high: 10, 50, 200, 50 ppb of diazepam, 
nordiazepam, and oxazepam in PBS buffer. C18 fibers preloaded with 
diazepam-d5. 2 min of extractions were performed. b constant can be 
calculated by eq 4.04 ( b = 1.01, 0.99, 1.21 for dizapem, nordiazepam, and 
oxazepam respectively). As listed in Table 4.2, theconcentrations of 
dizapem, nordiazepam, and oxazepam were calculated by q 4.06. The data 
showed that the calibrated results were very consistent with the true 
concentrations, as illustrated in Fig 4.4. 
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Figure 4.4. The calculated concentration Vs the true concentration of the three 





Table 4.2. The calculated concentration Vs the true concentration of dizapem, nordiazepam, 
and oxazepam (n = 3) with the single standard (dizapem-d5) calibration.  
Spiked 
concentration (ppb) 
Calculated concentration (ppb) and relative recovery 
Diazepam Nordiazepam Oxazepam 
10 10.0±0.4 (96-104%) 11.4±1.1 (103-125%) 10.7±1.9 (88-126%) 
50 50.3±1.2 (98-103%) 48.7±4.8 (88-107%) 53.5±6.6 (94-120%) 
200 201±3 (99-102%) 204.8±8.9 (98-112%) 207.9±17.3 (95-113%) 
500 498±11 (97-102%) 516.2±38.3 (96-111%) 505.7±46.2 (92-110%) 
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4.3.4 Calibrant-Free Kinetic Calibration for Multiple Analytes  
So far all the kinetic calibration methods developed are based on the 
symmetric relationship between absorption/adsorption and desorption. 
Therefore, the standard is needed to track the mass tr n fer kinetics of the 
analyte during sampling. However, the kinetics of absorption/adsorption can 
be characterized by the sampling itself, if we perform the sampling twice 









t −=−              （4.09） 
where t1 and t2 are the sampling time for the first and second sampling, n1 
and n2 are the amount of analytes extracted during t1 and t2 respectively, and 
ne is the amount of analyte that could be extracted when equilibrium 
extraction is performed. In this equation, n1 and n2 are detectable and t1 and 
t2 are known, so the ne value can be calculated. Then we can calculate the 
sample concentration, C0, with the established equilibrium-extraction 
equation: ffse VKCn 0= . The in vitro experiment has been conducted in 
plasma sample spiked with high concentration (500 ng/ml) and low 
concentration (1 ng/ml) of diazepam, nordiazepam and oxazepam. The 
sampling time is 1 min and 2 min respectively. The results were without 
significant difference from those using the traditional kinetic calibration 
with standard and the equilibrium sampling method (Table 4.3).  
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Table 4.3. The calculated concentration Vs the true concentration of 
dizapem, nordiazepam, and oxazepam (ppb) with the diff rent calibration 
methods. C0: the initially real concentrations of the plasma sample. C0
1: the 
detected concentrations with equilibrium extraction. C0
2: the detected 
concentrations with pre-equilibrium extraction and multiple deuterated 
standards. C0
3: the detected concentrations with pre-equilibrium extraction 
and nondeuterated standard. C0
5: the detected concentrations with 






Diazepam 1 0.9±0.1 1.5±0.9 1.3±0.4 1.3±0.5 
Diazepam 500 512.2±24.3 511.4±22.7 541.3±51.8 533.4±54.1 
Nordiazepam 1 1.1±0.2 1.1±0.3 0.9±0.4 0.6±0.6 
Nordiazepam 500 504.2±17.9 539.5±29.7 479.3±54.3 486.8±69.2 
Oxazepam 1 0.9±0.2 1.2±0.2 1.3±0.6 1.6±0.7 
Oxazepam 500 470.1±46.0 454.3±30.4 542.9±66.5 562,1±58.7 
 
    Actually, the calibrant-free approach can be performed in a single 
time-point mode to monitor a dynamic process. The basic idea is that the 









−−−=                 (4.10) 
Since a value is independent of sample concentrations and keeps constant 
through all the time-points, we can use it to calcul te the values of ne at 





=                        (4.11) 
Then ne can be used to calculate the sample concentration t that time-point.  
    The calibrant-free calibration method provides the most cost-effective 
SPME sampling strategy for multiple analytes with comparable quantitative 
capability. Furthermore, the multiplexing capability can be unlimited in 
theory because in nature it is a self-calibration method for every analyte; 
therefore any analyte can be calibrated as long as its difference in quantity 
can be reliably detectable between the two samplings. Experimentally, the 
sampling can be performed in parallel with two fibers, or in series with one 
fiber for two sequential sampling, but in the latter case, one desorption step 
should be conducted in between and the fiber must be reusable without 
changing its performance after the first use in complicated matrix.        
  
4.3.5 Evaluation of the Quantitative Capability of the Simplified 
Calibration Methods 
   Quantitative capability is one of the most important virtues of SPME 
technique. We want to simplify the sampling procedur s but not sacrificing 
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the quantitative capability. Therefore, the following five calibration methods 
were compared in terms of accuracy for in vitro monitoring in plasma 
samples: the equilibrium sampling with calibration curve method and the 
pre-equilibrium sampling based on kinetic calibration with multiple 
deuterated calibrants, single deuterated calibrant, single non-deuterated 
calibrant, and without calibrant. The results were shown in Table 4.3, which 
showed that there was no significant statistic difference (one-way ANOVA 
and post-hoc Tukey’s test, P<0.05) between these kinetic calibration 
methods, although the standard deviations were a little bit larger than those 
from the equilibrium extraction, which was ascribed to the less stability of 
pre-equilibrium SPME than equilibrium SPME, rather than the calibration 
method itself. And it must be noticed that the relatively higher recovery of 
the equilibrium SPME in the in vitro monitoring does not ensure the better 
accuracy for the dynamic pre-equilibrium in vivo monitoring. Actually as 
discussed before, the external calibration has inherent limitations in 
quantifying the pre-equilibrium in vivo sampling due to the difficulty of 
reproducing the matrix and agitation effect of in vivo situations in an in vitro 
environment.  
    Regarding sensitivity issue, the calibration does not affect the detection 
limit of the methods; however, the sampling strategies adopted affect the 
sensitivity. For example, in this study, the pre-equilibrium SPME (detection 
limit: 5-7 ng/mL for diazepam, nordiazepam and oxazepam in blood, 2 min 
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sampling) has lower sensitivity than equilibrium SPME (detection limits: 
1.4-2.8 ng/mL for diazepam, nordiazepam and oxazepam in blood, 15 min 
sampling). Therefore, as above-mentioned, the sampling time should be set 
to ensure that there are 30% ne of analyte extracted.  
For the in vivo pharmacokinetic studies, we compared the SPME results 
from the kinetic calibration with multiple deuterated calibrants, with a single 
deuterated calibrant, with a single non-deuterated calibrant, and without 
calibrant; afterwards, the SPME results were validate  by the conventional 
chemical analysis, as shown in Fig 4.5. The statistics (one-way ANOVA and 
post-hoc Tukey’s test) showed that there was no significant difference 
between the each of the four groups of data from pre-equilibrium SPME and 
the equilibrium SPME at P<0.05. The latter is highly correlated with the 
data from conventional analysis. The correlation coefficients (r) between 











Figure 4.5. Pharmacokinetic profiles of diazepam (1), nordiazep m (2), and 
oxazepam (3) were monitored by conventional assay and in vivo  SPME over 8 
hours on three dogs (n = 6 for the last point, and n = 9 for all the other points). 
Error bars were based on standard deviations (S. D.) A: Conventional assay; B: in 
vivo  SPME based on equilibrium extraction; C: in vivo SPME based on 
equilibrium extraction; B: in vivo SPME based on equilibrium extraction; D: 
Pre-equilibrium SPME based on kinetic calibration with multiple deuterated 
standards; E: Pre-equilibrium SPME based on kinetic calibration with single 
deuterated standard (diazepam-d5); F: Pre-equilibrium SPME based on kinetic 
calibration with single non-deuterated standard (diazepam) F: Pre-equilibrium 





4.4 Conclusion  
 
4.4.1 Conclusion 
In order to improve the automation potential and quantitative capability 
of SPME, we proposed three ways to simplify traditional kinetic calibration. 
The first simplification is temporal, where the single time-point desorption 
based kinetic calibration was proposed to replace the traditional multiple 
time-point method. The second approach focused on quantity, where the 
traditional multiple standards based calibration was simplified into the 
single-standard calibration and the standard-free calibration method. 
Thirdly, the kinetic calibration based on non-isotope labeled standards was 
developed as an alternative to the isotope-labeled standards employed in the 
traditional kinetic calibration method to obtain reliable calibration. The three 
simplifications can be combined; for instance, the single time-point kinetic 
calibration with a single nondeuterated standard or without any calibrant 
might be used to calibrate multiple analytes at multiple time-points 
throughout an experimental course. Thus in vivo SPME can be preformed 
not only easily and rapidly, but also accurately, so as to yield high 
quantitative capability and temporal resolution. Finally, it is worth 
mentioning that these simplified sampling and calibr tion approaches are not 




Development of High Spatial Resolution Solid-Phase 
Microextraction for In Situ Sampling  
 
5.1 Preamble and Introduction  
5.1.1 Preamble  
This chapter has not been published. Jibao Cai and François Breton 
contributed to this project. The contributions of François Breton involved 
the experimental suggestion, and Jibao Cai contributed to the instrument 
analysis.  
 











5.1.2 Introduction  
As a fast, simple and solvent free sampling and sample preparation 
method, Solid-phase Microextraction (SPME) has gained wide application 
from environmental studies to in vivo pharmacokinetics;1-8 however, up to 
date most applications have been restricted to relativ y homogeneous 
sample systems, such as lake water, air or blood. In some cases, when 
heterogeneous sample, such as soil, is to be analyzed, headspace SPME 
provides the operational convenience and avoids the complicated matrix 
effects.9 In these situations, spatial resolution does not need to be 
considered. Consequently, only spatially averaged rsults along the 
longitudinal dimension of the extraction phase are obtained. But, there are 
some situations where in situ sampling for heterogeneous systems is 
conducted, for example, studying the local concentrations in plant or animal 
tissues where spatial resolution of the SPME fiber plays an important role in 
accurately quantitative analysis. However, the tradi ional SPME approaches 
are not compatible with this aim due to the relatively big size of the fiber 
coating compared to the sampling locus. For example, to study the 
concentration and translocation of pesticides within living plants, 
commercial SPME fibers were applied for herbicides in an onion bulb, but 
the results were quite qualitative rather than quantitative.10 There are several 
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reasons for this outcome. Firstly, the detected tissue concentrations of the 
herbicides in a specific locus were not in real-time but time-averaged. This 
is because of the fact that diffusion occurring in the 1 hour of sampling time 
obscured the concentration difference between the locus under study and its 
neighborhoods. Secondly, the 1 cm length of the fibr utilized for the 
onion’s heterogeneous structure can only obtain spatially averaged 
concentrations along the 1 cm length; therefore, it provided a poor spatial 
resolution. Lastly, the cumbersome desorption process s riously affected the 
quantitative capability and reproducibility of the analysis. Actually, it is the 
physical dimension of the probe that determines the spatial resolution of the 
SPME technique, whereas the fast sampling strategy o obtain real-time 
concentrations is also necessary to ensure the highspatial resolution 
technique to be significant. In another word, mainly determined by its probe 
size, the spatial resolution of a sampling technique is related to its temporal 
resolution too.  
The requirements for high spatial resolution SPME can apply to other 
in situ sampling techniques, such as microdialysis (MD). As a 
well-established approach, high spatial resolution MD has been 
commercialized and applied for in situ sampling in living systems. For 
example, it has been widely applied to study the neurochemistry in brains 
and tissue specific pharmacokinetics.10-12 However, with faster mass transfer 
kinetics and unique enrichment capability, SPME might have better 
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sensitivity as well as higher spatial and temporal resolution for in situ 
sampling.  
The objective of this chapter was to develop a novel SPME technique 
with high spatial and temporal resolution for fast in situ analysis in 
heterogeneous samples. Its feasibility to real sample analysis was tested by 
investigating the concentration distribution of diazepam within an onion 




5.2.1 Overview of Experiments.  
In this chapter, a model system was developed for high spatial 
resolution SPME. This model uses a miniaturized format of SPME fibers 
and a heterogeneous sample system constructed by multilayered agarose gel 
with varied drug concentrations in different gel layers. The 
diffusion-controlled mass transfer within the gel medium was investigated. 
Fast sampling based on pre-equilibrium SPME with kinetic calibration was 
conducted to study the local concentration of the diazepam within a 1 mm 
layer of gel. The partition coefficient, K, and the fiber volume, Vf, were 
calculated from the calibration curve based on equilibrium extraction in the 
gel matrix. Finally, the high spatial resolution SPME was applied to study 
the distribution of diazepam in an onion. To demonstrate the feasibility of 
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the novel SPME method for in situ application, the results were validated by 
microdialysis (MD). All the SPME and MD experiments were conducted at 
room temperature, unless otherwise mentioned. 
 
5.2.2 Preparation of the Miniaturized SPME Probes 
The C18 particles (10 µm) and polyethylene glycol (PEG) were 
obtained from Supelco (Bellefonte, PA). C18 coated fibers were prepared 
and utilized according to the method described previously.14 An additional 
step was needed to cut or remove the part of coating using a rajor blade thus 
leaving two separated 1 mm coating segments remaining on the wire, one 
segment at the tip of the wire with a 5 mm spacing from the other segment, 










1mm fibre coating 




Figure 5.1. The two-segment SPME fibers. The length of each coating 
segment is on 1 mm. 
 
5.2.3 Loading Deuterated Standards onto SPME Fibers 
    For performing kinetic calibration, the fibers were preloaded with a 
deuterated standard (i.e., diazepam-d5) obtained from Cambridge Isotope 
Laboratories (Andover, MA). The 50 µg/L loading solution was prepared by 
spiking diazepam-d5 into 25 mL of sterile deionized-water. Then, the probes 
were exposed to the loading solution for 30 min to perform equilibrium 
extraction (standard loading) and then, stored in clean test tubes for use. 
5.2.4 Modeling of Heterogeneous Sample with Multilayered Gel 
Agarose gel (1%) prepared in phosphate buffered saline (PBS, pH 7.4) 
was used to simulate the tissue sample. Every 8 mL gel medium containing a 
given concentration of diazepam (Cerilliant, Austin, TX) was cast in a 10 ml 
screw cap vial (Supelco, Bellefonte, PA). The extraction behaviors of the 
SPME probes, including extraction time profile, desorption time profile, 
matrix effect of agarose gel, dynamic range of the extraction and symmetry 
of the extraction and desorption, were conducted in the gel matrices. 
To determine the diffusion velocity of diazepam in 1% agarose gel, the 
gel was cast in the round PYREX crystallization plate (125 X 65 mm) with a 
thickness of 13 mm, as shown in Fig. 5.2. SPME fibers (8 fibers) were 
placed in a circle around the plate center with a radius of 30 mm and 45°
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angle between each two adjacent fibers. Diazepam (20 µg) in 10 µL 
methanol was applied in the plate center with a Micropipette. SPME fibers 
were taken out one by one after every 40 min, briefly rinsed with pure water 
and then desorbed in 200 µL of HPLC grade methanol (Caledon 
Laboratories Ltd., Georgetown, ON, Canada) for 10 min. Finally, the 
methanol was evaporated by nitrogen gas, and the sample was reconstituted 
in 30 µL of reconstitute solution (50% acetonitrile and 50% nanopure water) 
with 7.5 ng/mL lorazepam as internal standard.    
To model the heterogeneous sample system, gel of multiple layers was 
cast in a 15 mL plastic Falcon tube. Upward from the bottom, the first 10 cm 
long supporting gel layer (without diazepam in it) was followed by casting 1 
mm thick layer (with 1 ppm of diazepam) and 5 mm long blank gel layer 
(without diazepam). Afterwards, another 1 mm thick gel layer with 2 ppm of 
diazepam was cast above the 5 mm blank gel layer. Finally, 10 mm blank 
gel was cast at the top. It should be mentioned that the following layer was 
not cast until previous layer had been solidified at 4 °C for 30 min. The 
positions of the two layers with the drug (i.e., diazepam) were labeled on the 
tube surface with a marker pen, so that the coating segments of the fibers 
can be positioned precisely within the layers with diazepam. To introduce 
the microdialysis probes, two small holes were drilled on the sidewall with a 
distance of 5 mm at the exact positions of two drug layers. The gel layer 




Figure 5.2.  Study of diffusion controlled mass transfer. Agarose gel (1%) was 
cast in the round crystallization plate with a thickness of 13 mm. SPME fibers (8 
fibers) were placed in a circle around the plate center with a radius of 30 mm and  
45° angle between each two adjacent fibers, as labeled y the numbers from 1 to 8. 
Diazepam in 10 µL methanol was applied in the plate center at t = 0. 
 
In a triplicate sampling experiment, the segmented fiber preloaded with 
deuterated diazepam was introduced into the gel and stopped at the exact 
two layers containing diazepam. Sampling (i.e., extraction) was performed 
for five minutes. In order to avoid concentration contamination, the fiber 
was protected with the needle when the fiber was introduced and withdrawn 
from the gel. A two-step successive desorption was conducted to desorp the 
extracted analyte and calibrant from the two coating segments into two wells 
of a 96-well plate, respectively. As shown in Fig. 5.4, first, the fiber was 
desorped into a well with 50 µL of 100% methanol for 2 min, where the 
SPME fiber 
Gel in plate 
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level of the methanol was only high enough to immerse the first coating 
segment at the tip of the wire. Then, fiber was put into another well for 2 
min containing 200 µL of methanol (100%). The level of methanol was high 
enough to immerse the second coating segment for desorption. Finally, the 
methanol in both wells was evaporated, and the samples were reconstituted 




Figure 5.3. Simulation of a heterogeneous sample system with multilayered gel in 
a plastic Falcon tube. High spatial resolution SPME and microdialysis were 
conducted to determine the drug distribution in the multilayered gel system. 
 
The segmented SPME 
fiber 
Microdialysis Probes within the 
guide cannula  
Gel-layer with 2 ppm 
diazepam 





Figure 5.4.  The two-step desorption process in a 96-well plate for the extracted 
analyte and calibrant. A, the segmented fiber; B, the fiber placed into 50 µL of 
methanol (100%) in a well for 2 min to desorp the analyte from the first coating 
segment; C, the fiber placed into another well containing 200 µL of methanol 
(100%) to desorp the analyte from the second coating segment. 
 
For the purpose of validation, two microdialysis probes were placed 
into the two gel layers, respectively while performing SPME sampling. The 
microdialysis perfusion fluid was nanopure water, and the flow rate of the 
perfusion fluid was 2 µL/min. Then, the dialysates were collected in 10 min 
interval and mixed with 20 µL of acetonitrile for LC-MS/MS analysis. 
A B C 




Quantification of the analyte concentration in microdialysis samples was 
based on the recovery of the analyte, Cdialysate/Cperfusate.
12 
The limits of detection (LOD) and dynamic range of high spatial 
resolution SPME and microdialysis were studied separately using standard 
solutions with various concentrations (0.1 to 500 ppb) in gel medium.  
 
5.2.5 Real Sample Application: Study the Local Concentration of 
Diazepam in an Onion Bulb 
To study the local concentration in a real sample, an onion bulb with a 
diameter of 6 cm, was chosen because of its layered st ucture, which made it 
suitable to serve as a heterogeneous sample model. Methanol/water (10:90, 
v/v %) of 0.2 mL containing 1 µg/mL of diazepam was injected into the 
centre of the onion bulb from the stem side 4 hours before the sampling. 
Towards the axial of the onion, two parallel holes with a length of 1.9 cm 
were made with a 22 gauge hypodermic needle. The distance between the 
two parallel holes was 2 mm. The segmented SPME fiber was introduced 
into one hole while a 4 mm microdialysis probe (CMA/12, 
CMA/Microdialysis AB, Stockholm, Sweden) was placed into another hole 
to validate the results from SPME. The schematic for the experimental setup 



















Figure 5.5. The schematic showing the use of the high spatial resolution SPME and 
microdialysis for in situ sampling in an onion bulb. 
 
After 5 min, the fiber was pulled out and briefly rinsed with nanopure 
water to remove any adhered plant-bulb material, followed by the two-step 
successive desorption. Afterwards, the fiber was dried in air and stored in 50 
mL pure water. The sampling process was conducted for 3 times. The 
1 2 






Diazepam injected into the onion  
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microdialysis perfusion fluid, flow rate and the calibration procedure were 
the same as for the gel experiment.  
 
5.2.6 LC-MS/MS Analysis 
 A CTC-PAL autosampler/Shimadzu 10 AVP LC/MDS Sciex API 
3000 tandem Mass Spectrometry (MS) system was used for the analysis of 
the drugs and their deuterated standards. The assayconditions were the same 
as described in the literature.4 Briefly, the column was a Waters Symmetry 
Shield RP18, 2.1 × 50 mm with 5µm particle size (Millford, MA). Mobile 
phases were (A) acetonitrile/water (10%: 90%) with 0.1% acetic acid and 
(B) acetonitrile/water (90%:10%) with 0.1% acetic acid. Mobile phase flow 
rate was 0.5 mL/min, and the gradient used was 10% B for the first 0.5 min. 
This was ramped to 90% B over 2.0 min, held for 1.5min and finally 
returned to 10% B for 1 min. This provided a total of 5 min run time 
including reconditioning. For experiments with the onion, LC effluent was 
directed to waste for the first 1 min of run time to prevent co-extracted 
compounds from entering the MS instrument. During this divert time, a 
makeup flow was supplied to the MS via the quaternary pump. The HPLC 
effluent was analyzed by ESI (positive ion mode) with selected reaction 
monitoring. Transitions monitored were diazepam: m/z 285.0/154.1, 
diazepam-d5: m/z 290.2/154.1 and lorazepam: m/z 321.1/ 75.1.  
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5.3 RESULTS AND DISCUSSION  
5.3.1 Improvement of Spatial Resolution by Reducing the Size of the 
SPME fiber  
Normally, uneven distribution of a substance within a atural system is 
much more common than uniform distribution due to the heterogeneous 
nature of the system in most cases. Therefore, for monitoring the dynamic 
physiochemical process of a substance within a heterogeneous sample 
system, for example, studying the clinical pharmacokinetics in an animal 
organ or plant tissue, spatial resolution of the investigating technique is 
important and deserves more attention. In this study, the spatial resolution of 
an in situ sampling technique is defined as its capability to accurately 
determine the local concentrations of analytes and clearly resolve two 
different concentrations spatially close to each other.    
The traditional SPME technique has been widely applied to gas or 
liquid samples, but it has not been used in heterogeneous sample where the 
spatial resolution is required. As discussed above, th  spatial resolution of 
SPME is determined by the size or dimension of its extraction phase. So, 
resolution may be improved by reducing the fiber size. However, the 
sampling time, that determines the temporal resolution of the technique, 
should also be considered at the same time. This is because of the fact that 
the diffusion of analytes during a long sampling time tends to uniform the 
concentration distribution in the adjacent area, thus making the spatial 
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resolution meaningless. Consequently, for SPME experiments, the effect of 
reducing sampling time should be considered together with shrinking the 
fiber dimension. Furthermore, the mass transfer kinetics 
(diffusion-controlled) in a soft tissue is quite slow compared to that in 
headspace gas or agitated liquid. Therefore, the SPME coating should 
possess a fast equilibrium time and high extraction capacity to meet the 
requirements. In this research, C18-bonded silica particle (5 µm) coated 
fibers were selected as the extraction phase becaus of its relatively high 
extraction capacity and fast equilibrium time. 14 To improve the spatial 
resolution, the length of the coating was chosen to be 1 mm. In static 
extraction condition, it was able to extract 30-40 pg of diazepam from 1% 
gel sample in a fast equilibrium time, i.e., 15 min.  
 
5.3.2 Study of Drug Diffusion and SPME Extraction in the Gel Medium           
In a small heterogeneous dynamic living system, such as, an onion 
bulb, obtaining the real-time in situ concentration with traditional techniques 
is really challenging. Actually, it is impractical to obtain the instant 
concentration with equilibrium-based SPME, because, during the time to 
reach equilibrium between sample matrix and extraction phase, the analyte 
concentration at a specific locus would change due to diffusion within the 
heterogeneous system. To address this issue, non-equilibrium SPME 
technique (fast SPME) was adopted to obtain nearly real-time 
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concentrations. However, the concentration variation resulting from the 
diffusion effect depends not only on the sampling time, but also on the 
diffusion velocity of the analyte species under a certain temperature in the 
sample matrix. Therefore, we determined the linear v locity for the diffusion 
of diazepam molecules in the gel medium at room temperature. It was found 
that diazepam could not be extracted by the SPME fiber until 5 hr was 
passed. This meant that it took 5 hr for the molecules to pass through 30 mm 
distance in the gel medium and reach the fiber coating. Thus, the diffusion 
velocity was calculated to be ~ 1.67 µm/sec. This indicated that the 
concentration changed quite slowly. Therefore, in the gel medium, the 
concentration change due to the diffusion during 5 – 15 min was negligible. 
Accordingly, 5 min was selected as the sampling time for the multilayered 
gel system.  
Additionally, the diffusion coefficient of the analyte molecules in the 
gel medium, D, could be determined with the SPME technique according to 






=                  (5.1) 
where, x is the moving distance of the analyte via diffusion, and t is the time 
duration of the molecule migration via diffusion. The calculated diffusion 
coefficient was in the range of 1x10-9 m2/s.  
It should be mentioned that the main cause of concentration variation in 
the gel model system is the physical diffusion. However, for in vivo analysis 
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in a living system, such as detecting a metabolite in a living animal, the 
situation could be different, where metabolism plays n important role in 
varying the drug concentration as physical diffusion does. Thereby, the 
temporal resolution of the analytical approach deserves more attention. In 
those cases, investigating the contribution of physical diffusion and chemical 
metabolism to local tissue concentration of target analytes, such as a drug or 
neurotransmitter, would be quite suggestive to reveal its functional 
mechanism.    
 
5.3.3 Kinetic Calibration for the in situ Sampling 
For non-equilibrium extraction, as discussed previously, kinetic 
calibration outweighs calibration curve method providing more accurate and 
precise calibration. 14-17 This approach is especially suitable for achieving 
real time in situ sampling. However, the first prerequisite of kinetc 
calibration to be met is the symmetric relationship between the extraction 
and desorption processes of the analyte in sample matrix. Therefore, 
absorption and desorption experiments were conducte simultaneously to 
investigate the symmetry. The fibers preloaded with deuterated diazepam 
were exposed to a gel medium containing 200 µg/L diazepam (pH 7.4) for 
different times to study the fraction of the standard remaining in the 
extraction phase after sampling times (t). Figure 5.6 presents the values of 
Q/q0 that was calculated from the desorption time profile and n/ne from the 
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absorption time profile. The sum of Q/q0 and n/ne is close to 1 at each time 
point, which validates the symmetric relationship between the adsorption 
and desorption. In addition, the requirements for negligible depletion 
(nd-SPME) should be met; so that the sampling does n t disturb the system 
under study, and thus, this approach can be used to e ect the free 
concentration of analytes in a complicated sample matrix.18 The newly 
developed approach is featured by the negligible depletion during sampling 
due to its small fiber volume resulting from miniaturized dimension and 
shortened sampling time. In a1 mm thick gel sample with total volume > 0.2 
mL, only 2-4% of the free fraction of diazepam was extracted in 5 min. As a 
result, the detected sample concentration is not affected by the sample 
volume; thus making the quantification simpler and more convenient. In 
addition, sensitivity of the 1 mm SPME fiber should be considered. In the 
gel experiment, it was shown that the detection limit of 1 mm high spatial 
























Figure 5.6. The absorption and desorption time profiles for diazepam (◊) and its 
deuterated analogues, diazepam-d5 (♦) in 1% agarose gel (at 25 ˚C). 
 
In order to obtain the sample concentration, external calibration method 
was used to determine the product of Vf and Kfs, the slope of the calibration 
curve for equilibrium extraction in gel-prepared standards at room 
temperature. Consequently, the free concentration and fr ction of the analyte 
can be obtained easily by comparing the calibration in gel medium and that 
in PBS buffer. It was found that the free fraction of diazepam in gel medium 
is ~ 73%. It suggests that the bound fraction of the analyte to the agarose gel 
is around ~ 27%.  
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5.3.4 Real Sample Analysis by SPME and Validation by Microdialysis 
    To test the feasibility of the high spatial resolution SPME, the local 
concentrations at two sampling sites (labeled as 1 nd 2 in Fig. 5.5), that 
were located in different depth along the needle-made-hole in the onion 
bulb, were monitored. The calculated concentrations (ppb or ng/mL) at the 
two sampling sites based on the results from the triplicate extractions are 
presented in Table 5.1. Data from microdialysis experiments are also 
presented in Table 5.1 to compare with the data from SPME experiments. It 
was found that there was no significant difference between the three 
extractions at each location; however, the concentrations that are reflected 
by the extracted amount were significantly different between the two 
locations with the two coating segments. The extracted amount at the tip 
coating was about 4 - 5 times higher than that from the upper part coating. 
This result indicated the very heterogeneous nature of the onion bulbs; 
meanwhile, the difference demonstrated the spatially resolved capability of 
the segmented SPME. However, the determined concentratio  from the 
microdialysis probe in the 1.9 cm long hole is just 3 times lower than that 
from the SPME fiber segment at sampling site 1, but 2 times of that from the 
SPME fiber segment at the sampling site 2. Apparently, the calculated 
concentrations from SPME results did not match those from microdialysis. 
In fact, with 4mm-probe (lower spatial resolution than 1mm SPME fiber), 
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the microdialysis probed the averaged concentrations in a much wider range 
along the lengthwise holes, i.e., 4 mm in length from the tip, rather than the 
1 mm range concentration sensed by the SPME fiber. Therefore, the 
concentration from the microdialysis probe in the 1.9 cm long hole could be 
regarded as the spatially weighted average of the concentration as 
determined by the two SPME segments. This rationale was supported by 
introducing 4 mm C18-coated SPME fibers into the 1.9 cm hole along with 
the MD probe for a 5 minutes extraction. The obtained concentrations 
agreed with those from MD probe. Therefore, the results demonstrate that 
the quantitative capability of the SPME is comparable to the microdialysis, 
making SPME device suitable for the quantitative in situ analysis. 
Table 5.1. Application of the segmented fibers for in situ analysis of real 
time local concentrations in two loci with 5 mm distance in an onion bulb. 
The SPME data were validated by microdialysis, and concentration unit was 
ppb (ng/mL). 
 Sampling sites Site 1  Site 2 
Trial # SPME 1 SPME2 MD SPME1* MD 
1st 633 275 298 131 N/A 
2nd 625 267 289 127 N/A 
3rd 626 261 277 119 N/A 
 Footnote:  
1. SPME 1: The 1 mm fiber segment at the tip of the wire located at site 1 in the 
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onion bulb. 
2. SPME 1*: The 1 mm upper fiber-segment located at site 2 with 5 mm in 
distance from the site 1. 
3.  SPME 2: The 4 mm fiber coating at the tip of the wire located at site 1 in the 
onion bulb together with the MD probe. 
4. No MD probe at site 2 (N/A: not applicable). 
    Compared to the high spatial resolution SPME that can detect the 
concentrations in the two adjacent locations simultaneously with a 
segmented fiber, each microdialysis probe can only be applied to one single 
determination. Furthermore, the multiplexing capability of SPME can be 
further improved by preparing multiple segmented fiber coating on a single 
wire. On the contrary, there is a lack of multiplexing capability for 
microdialysis technique. Moreover, the SPME device is much simpler and 
more compact than the microdialysis sampling as the latt r includes a needle 
syringe, tubing and microinjection (syringe) pump. For calibration, the 
kinetic calibration is not only accurate, but also time-saving so that it 
ensures the temporal resolution of the SPME sampling. However, for 
microdialysis, determining the % recovery is more time consuming and 
labor intensive. More importantly, from the gel expriment, the limit of 
detection for a 4 mm microdialysis probe (i.e., 5 ppb) is 2 time higher than 
that of 1 mm high spatial resolution SPME (i.e., 2.5 ppb). Therefore, the 
SPME method could have higher sensitivity than the microdialysis if the 
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MD probe could be made in the same size. However, the microdialysis 
sampling has some advantages. As a continuous online-sampling technique, 
it is easy to be completely automated for the whole analysis process 
including sampling, sample preparation and sample introduction into an 
instrument for quantification, for example, coupling with a capillary 
electrophoresis device.19-22 In addition, MD probes can be employed as 
delivery tools for drugs or chemicals, while that is not suitable for SPME.23 
On the contrary, SPME is a discontinuous sampling technique, so more 
efforts are needed to achieve full automation for the bioanalysis, especially 
when studying nonvolatile molecules using LC-MS. Nevertheless, for in situ 
sampling, high spatial resolution SPME provides irreplaceable effectiveness 
and efficiency.   
 
5.3.5 Spatial-profile Sampling with the Segmented SPME Probes 
    During in situ sampling in a heterogeneous sample system, the purpose 
was to investigate the spatial distribution of target analytes at a given time. 
In order to achieve this goal, many probes were to place in the representative 
sampling sites. Moreover, all the individual samplings should be conducted 
simultaneously. This is too difficult or even impractical with the traditional 
sampling techniques, such as MD or traditional SPME.10 But the segmented 
design of the miniaturized SPME fibers and the stepwise successive 
desorption procedure provided the possibility to perform two parallel 
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samplings simultaneously with only a single probe. The multiplexing 
capability can be improved by increasing the coating segments to achieve 
spatial-profile sampling; however, the current 2-segm nt design serves as an 
excellent prototype for the one-dimensional spatial-profile probes. 
 
5.4 Conclusion  
5.4.1 Conclusion 
In conclusion, a high spatial resolution SPME approach was developed 
and evaluated in this work. The novel SPME method also showed high 
temporal resolution. A multilayered gel system was constructed to simulate 
a heterogeneous sample. Finally, real application was conducted for drug 
analysis in a very heterogeneous system, such as anonio  bulb. Compared 
to the microdialysis approach, the results demonstrated the feasibility, 
accuracy (relative recovery: 93%), sensitivity (LOD: 2.5 ng/mL) and 
efficiency (5 min) of the newly developed SPME sampling device. 
Moreover, the segmented design of the SPME fibers and stepwise 
successive desorption procedure offer not only the spatial resolution, but 
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Ochratoxin A (OTA), a secondary metabolite produced by several 
common toxigenic fungi (moulds), is one of the most widely-occurring 
nephrotoxic, carcinogenic and immunosuppressive toxins and is considered 
to be involved in severe pathological response from hu ans and animals.1-3 
Currently, it has become a major health concern and there is an increasing 
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need for accurate monitoring of this mycotoxin in food products.4-8 
However, traditional sample preparation approaches such as liquid 
extraction (LE) and solid-phase extraction (SPE), have proven to be 
time-consuming and labor-intensive. Antibody-based immunoaffinity 
chromatography (IAC) and active protein based affinity separation has been 
introduced for this purpose.9-10 However, the cost and the fragility of the 
non-reusable column prevent it from being usable with the complicated 
cheese sample matrix. Therefore, the need to develop fast and low-cost 
sample preparation approaches for OTA analysis in semi- olid food samples 
cannot be overemphasized.  
As an effective sampling and sample preparation method, solid-phase 
microextraction (SPME) has gained extensive application and recognition in 
many areas since it was introduced. 11-14 One of the key reason is its unique 
capability in integrating sampling, sample preparation, and sample 
introduction into one single step, and thus the total process of chemical 
analysis is greatly simplified. Although, SPME method was previously 
applied to the analysis of mycotoxins in cheese samples with good detection 
limits,15-16 the SPME fiber was only applied to the reconstituted sample 
extract after a liquid extraction step, thus making the procedure tedious and 
time-consuming.  
One of the objectives of this work was to introduce th  SPME fiber 
directly into the cheese sample so as to demonstrate the effectiveness of the 
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technique in performing in situ sampling and sample preparation. The 
chosen approach was effective and simple compared to previous liquid 
extraction methods. The extraction phase was acidified prior to sampling in 
order to improve extraction efficiency of OTA. Morever, the miniaturized 
size of the extraction phase coupled with fast in situ sampling would provide 
an effective space- and time-resolved approach for the detection of OTA 
levels at different sites in one small sized cheese sample and also the 
concentration variations with time. Generally the temporal resolution of the 
SPME is determined by its response time, or sampling time, while the spatial 
resolution is determined by the size of the extraction phase. Because the 
proposed method could provide good spatial (1 mm) and temporal 
resolution, it was further investigated whether thedata could be used to 
determine if the OTA contamination was originating from the fungus such 
as Penicillium verrucosum or from the raw materials that the cheese was 
made of. 
 
6.2 EXPERIMENTAL SECTION 
 
6.2.1 Chemicals and Materials 
OTA, Ochratoxin B (OTB) and other chemicals were of analytical 
grade and ordered from Sigma-Aldrich. (Oakville, Ontario, Canada). Stock 
solutions of OTA and OTB were prepared in methanol and stored at -20° C. 
Carbon-tape was from TAAB Laboratories Equipment Ltd (Calleva Park, 
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Reading Berkshire, United Kingdom). 0.01 inch stainless steel wires were 
purchased from Small Parts Inc. (Miami Lakes, FL, USA) and cut into 
pieces of 5-cm length.  
 
6.2.2 Preparation and Characterization of SPME fibers 
Carbon-tape fiber was used as the extraction phase for the sampling.17 
The carbon tape was cut into 1 mm X 1mm pieces and each piece was 
immobilized onto the end of one 5-cm stainless steel wire. The resulted 
carbon-tape based SPME fibers were 1 mm in length. All fibers were 
acidified with hydrochloric acid and preloaded with internal standard 
simultaneously. The loading solution was prepared by spiking OTB standard 
into 50 mL of diluted HCL aqueous solution (pH 2.0) at 100 µg/L. Then the 
fibers were exposed into the loading solution during 8 hours for standard 
loading.  
A systematic investigation was conducted to characte ize the extraction 
behaviors of the fibers including extraction time profile, desorption time 
profile, pH effect on the extraction, and dynamic range. All the 
characterization experiments were performed in 1% agarose gel medium to 
optimize the experimental conditions for cheese samples.  
 
6.2.3 Sampling and Sample preparation with SPME 
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Three semisolid cheese samples were monitored in this study. The aged 
Cheddar cheese was donated by Dr. Pawliszyn, while the “no name”® skim 
milk cheese were obtained in a local supermarket. The cheese was separated 
into three different sets. Set A comprised aged cheese allowed to develop 
mould stains while set B had no mould stains. Set C (No name®) had no 
mould stain however it was less matured compared to sets A and B. For set 
A cheese with the mould stain, two SPME fibers were introduced into two 
sampling sites at different distances from the mould stain. In the case of set 
B and C, three fibers were introduced in a triangular manner and a fourth 
fiber was placed at the center of this triangle. Sampling was done for 20 min 
after which the fibers were cleaned with Kimwipes® to remove any cheese 
residues attached to the surface of the coating. The fibers were later put into 
wells inside a 96-well plate containing 250 µL Polypropylene inserts and then 
150 µL of pure methanol was used for desorption of the analytes. Desorption 
was completed in 15 min with agitation on a mechanic l KV-300 shaker set 
at the speed of 100 rpm. Finally, 20 µL of desorptin solution was injected 
in LC-MS/MS system for quantification. 
 
6.2.4 LC-MS/MS Analysis 
A CTC-PAL autosampler/Shimadzu 10 AVP LC/MDS Sciex API 3000 
tandem MS system was used for the analysis of the OTA and OTB. Briefly, 
the column was a Waters Symmetry Shield RP18, 2.1 × 50 mm, 5 µm 
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particle size (Millford, MA). Gradient elution was performed with a flow 
rate of 0.5 mL min-1 for separation with mobile phase (A) acetonitrile/water 
(10: 90) with 0.1% acetic acid, and (B) acetonitrile and acetic acid 100:0.1. 
The gradient started with 10% B for the first 0.1 min, followed by a linear 
increase to 40% B in 6 min, and then it was ramped to 100% B in 0.1 min, 
held for 3 min before decreased to 10% B in 0.01 min. This provided a total 
8 min run time including reconditioning the column. For experiments using 
cheese samples, LC effluent was directed to waste for the first 2 min of run 
time, to eliminate co-extracts from entering the MS. The mass spectrometer 
worked in the negative ion mode. The m/z transitions were m/z 402.1/357.9 
and 402.1/314.0 for OTA, and 368.0/133.1 for OTB.      
 
6.2.5 Conventional Cheese Analysis  
In order to validate the SPME data, the traditional liquid extraction with 
methanol as the extraction phase was performed. About 0.05 g of cheese 
sample (n = 3) was weighed by difference in a preweighed 2 ml amber vial 
with a PTFE sealed screw cap. 1 ml pure methanol was added and the 
resulted mixture was sonicated for 30-min, followed by a 20-min 
centrifugation (15000 g). 900 µl supernatant was divided into 3 identical 
300-µL aliquots in 3 new 2-mL amber vials. 15 µL of standard solutions (0, 
100, and 200 ng/mL in pure methanol) were added into the three vials, 
respectively. Afterwards the solvent in the three samples was evaporated 
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under nitrogen gas. The residue was reconstituted with 100 µl mobile-phase 
A and subjected to instrumental analysis.  
In addition, standard addition was adopted to calibr te the conventional 
analysis in that it is suited to deduce how much endogenous analyte was in 
the original cheese sample with complicated matrix effect.18 Care should be 
taken to ensure that the calibration requires a linear response to the quantity 
of the analyte plus standard.  
 
6.3 RESULTS AND DISCUSSION  
Previous studies showed that the carbon-tape SPME fiber had 
significant affinity for OTA.17 It exhibited high extraction capacity and 
efficiency compared to the commercial fibers. However, the carbon-tape 
SPME fibers were applied to only homogenous and aciified liquid samples, 
which is totally different from performing in situ sampling in a semisolid 
sample such as a cheese. In the latter case, for in situ studies, to avoid 
damage the whole sample, it is impossible to treat the sample with chemicals; 
therefore, it requires a fiber with good sensitivity for the non-treated samples. 
OTA is a weak acid with the carboxylic group on thephenylalanine moiety 
(pKa = 4.4) and shows a strong dependence of extraction yield on sample pH. 
All the previous SPME experiments for the analysis of OTA were conducted 
around pH 3 by the adjustment of matrix pH.19-20 Considering the adjustment 
of matrix pH was not an option in the current study, a new strategy was 
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proposed which involved the acidification of extracion phase prior to 
sampling.  Secondly, in situ analysis requires the SPME fiber to have high 
spatial resolution; i.e., the fiber size must be mini zed to probe local 
concentrations in a small-sized sample. To address thi  requirement, the 
dimensions of SPME extraction phase were reduced to 1 mm x 1 mm. 
Finally, on-fiber standardization approach was used for quantitative 
analysis in order to keep sampling times as short as possible. 
 
6.3.1 Development of Acidified Mini-Carbon-Tape-Fibers  
Selection of the carbon-tape SPME fibers in this work was due 
primarily to its high extraction capacity.17 The extraction effeciency for 
OTA was strongly affected by the pH environment of the sampling. To 
address that, the fibers were acidified prior to sampling and tested in gel 
matrix. A pH series (pH = 1, 2, 3, 4, 5) of aqueous HCl solutions were 
prepared and the carbon tape-fibers (n = 3) were immersed in 10 ml of each 
of the acidic solutions in a 40-ml vial for 8 hours at room temperature. 
Afterwards, the fibers were used for extraction in agarose gel containing 10 
ppb of OTA. As presented in Fig. 6.1, the results showed the strong pH 
dependence of the extracted amount in both gel matrix and in the cheese. In 
addition, this data showed that the carryover for all extractions was similar, 
so the extraction difference was due to the different affinity of the fibers to 
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the analyte rather than the carryover. For subsequent experiments, aqueous 
solution of HCl at pH 2 was used to acidify fibers p ior to sampling.  
 
 
Figure 6.1. The pH dependence of OTA extraction using the mini-carbon-tape 
SPME fibers in gel matrix (n = 3). 
 
Another aspect for characterizing the acidified fiber was to study its 
extraction kinetics. We compared the extraction time profile of acidified 
fibers in a non-acidified sample matrix (1% agarose gel) with that of the 
acidified fibers in acidified gel matrix (1% agarose gel, pH = 3).  As shown 
in Figure 6.2, the two profiles were consistent, though the precision for the 
acidified fibers in a non-acidified sample matrix (RSD ~10%) was 
somewhat larger than sampling in the acidified gel (RSD ~5%). The 
agreement of results indicated that acidifying fibers was equivalent to 
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acidifying sample in terms of kinetic behavior (indicated by no change in 
time required to reach equilibrium) and thermodynamics (indicated by no 
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Acidified fibers in acidified gel
 
Figure 6.2. Comparison of OTA extraction time profiles by using acidified fibers 
in non-acidified gel prepared sample with using acidified fibers in acidified gel 
sample.   
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Figure 6.3. The SPME calibration curves of OTA and OTB developd with the 
acidified fibers in standards prepared in gel. 30-min samplings were performed 
under room temperature. 
 
Finally, we studied the linear relationship between the sample 
concentrations and the instrumental response, which was the pre-requisite 
for a quantitative analysis. The experiment was performed in 1% agarose gel 
with different OTA concentrations. Figure 6.3 present  the linearly 
proportional relation, which indicated the feasibility of using the acidified 
fibers for quantitative analysis. The linear range of the carbon-type SPME 
was 1.5-500 ng/mL. 
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Furthermore, for in situ analysis, the spatial resolution of the SPME 
fiber must be improved by a reduction in the size of the fibers. However, the 
reduction of the coating volume also decreases the sensitivity, so it was 
important to ensure that the amount extracted by the miniaturized fiber was 
still sufficient for this analysis. The results showed that the limits of 
detection and quantification for the 1 mm fiber in gel matrix was 1.5 and 3.5 
ng/mL respectively, which was with fairly good sensitivity for the analysis 
of Ochratoxin A in cheese sample according to the following SPME studies. 
 
6.3.2 On-fiber Standardization for Calibration 
     For in situ analysis of a cheese sample with SPME, another challenge 
is the correct calibration, since the three traditional calibration methods 
including external calibration curve, standard addition method and internal 
standard method, are not applicable for the in situ study. However, the 
on-fiber standardization method, or called kinetic calibration, provides the 
solution for accurate on-site sampling for it compensates for the agitation 
effect and matrix effect.21-25 As a specific case of on-site sampling, in situ 
sampling is theoretically appropriate for on-fiber standardization. The 







=                (6.1)  
where C0 is the initial concentration of analyte, Q is the amount of standard 
remaining in the extraction phase after exposure of the extraction phase to 
 141
the sample matrix for the sampling time, Vf is the volume of the fiber, Kfs is 
the fiber coating/sample distribution coefficients of the analytes, and q0 is 
the amount of standard that is pre-loaded in the extraction phase. 
However, the typical kinetic calibration is based on the use of 
isotopically labeled compounds as standards, which was not applicable for 
the OTA analysis because its isotopically labeled analogue is not 
commercially available. Herein we use OTB as the standard to calibrate 
OTA extraction. However, two requirements must be satisfied so that OTB 
can be directly used for the on-fiber standardization of OTA: (1) there 
should be no endogenous OTB in the sample; (2) the tim  constant of the 
extraction of OTA should not be significantly different from that of OTB in 
the same matrix. In addition, it is worth noting when calculating the OTA 
concentration based on eq. 6.1, Kfs must be the distribution coefficient for 
the analyte OTA, rather than that for the analogue OTB, which was used as 
the standard. In order to satisfy these requirements, firstly, it was confirmed 
that no OTB was present in the cheese sample using traditional liquid 
extraction. Secondly, the extraction time profiles for OTA and OTB in gel 
matrix were compared. As shown in Fig. 6.4, there was no significant 
difference between OTA’s and OTB’s equilibration time, and equibration 
time is an indicator of the magnitude of time consta t. Actually, the time 
constant, a, could be calculated by fitting the extraction time profile into the 
following mathematical model:  
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Figure 6.5. Validation of the on-fiber standardization using OTB as the standard 






−−=              (6.2) 
where n is the amount of analyte in the extraction phase during each 
sampling time t, ne is the amount of analyte in the extraction phase at 
equilibrium, a is the time constant. Here, the a values were calculated as 
0.85 and 0.77 hr-1 for OTA and OTB respectively. The small difference in 
the magnitude of a value would not result in significant deviation from the 
isotropism relation between desorption and adsorption, which was explained 
in detail elsewhere.21-22 Therefore, OTB could serve as the standard for OTA 
monitoring. 
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Moreover, a proof of principle experiment was conducted in gel matrix to 
test the validity of using OTB to calibrate OTA. As shown in Fig. 6.5, the 
calculated relative recoveries were around 93% (5 - 500 ng/mL), shown as 
the slope of the linear regression, which demonstrated the accuracy of the 
method. 
Last but not least, in order to obtain sample concentrations with 
on-fiber standardization, the product of Vf and Kfs of the analyte must be 
determined.26 In this report, a simple method was proposed to deermine the 
Kfs • Vf  values of the carbon tape fiber in semisolid cheese sample. The 











==                   (6.3)     
The eq. 6.2 can be rewritten as  
seffs CnVK /=                       (6.4)     
where ne is the amount of OTA extracted in equilibrium SPME and Cs is the 
sample concentration of OTA in cheese samples. Herein, we used the 
equilibrium SPME method to obtain e and then detected the sample 
concentration with traditional organic solvent (methanol) extraction. First of 
all, the SPME fibers were put into the cheese sample for 10 hours to ensure 
the equilibrium extraction.17 Then the traditional liquid extraction was 
calibrated by standard addition method to compensat for the matrix effect. 
Finally, the calculated Kfs • Vf  value ranged from 0.15-0.22 µl for three 
different semi-solid cheese samples.   
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    Experimentally, to streamline the operation procedure we combined the 
fiber treatment with acids and the standard loading into one single step. The 
experimental results showed that there was no significa t difference between 
performing the two steps separately and simultaneously (data not shown). 
Therefore the carbon-tape fibers were loaded from acidic OTB aqueous 
solution (pH = 2) in all subsequent experiments. 
 
6.3.3 In Situ Cheese Analysis  
The application of the proposed in situ SPME approach to real sample 
analysis was demonstrated by analyzing 3 different semi-solid cheese 
samples as described in the experimental section, in wh ch both the spatial 
concentration-distribution and the concentration change over time were 
studied. The results are presented in Table 6.1. It was found that for Set A 
with a mould stain, the OTA concentration had an inverse relation with 
distance between the sampling site and mould stain. However, the amount of 
OTA detected was directly proportional to storage time for mouldy cheese 
(set A), as shown in Fig. 6.6. This data indicated presence of live fungi in 
the cheese. If the fungi were not intentionally inoculated into the cheese 
during manufacturing, it could be safely speculated hat the fungi were 
contaminated during transportation, storage or manufact ring, for example, 
from flaws of the packages. For the Set B without mould stains, the uniform 
distribution of the OTA concentration was observed; moreover, the OTA 
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concentration did not change during the 2 weeks. This result indicated that 
there were no active fungi that produce OTA in the c ese and the raw 
materials were the likely origin of contamination. I  the case of Set C cheese 
sample, there was no detectable OTA. Based on these results, it is safe to 
conclude that the in situ SPME approach could be used to track the possible 
OTA contamination sources in cheese products.  





































Figure 6.6. The OTA concentration change in the Cheddar cheese during the two 
week storage in 4 ˚C refrigerator. Cheese 1: the aged Cheddar cheese with a 
mould stain. Cheese 2: the aged Cheddar cheese without mould stains. 
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The SPME results were consistent with those obtained by traditional 
liquid extraction (LE) that was calibrated by standrd addition, as shown in 
Table 6.1, which proved the validity of the in situ SPME analysis. 
Meanwhile, the SPME sampling with on-fiber standardization method was 
simpler and faster than using the LE coupled to standard addition. It must be 
admitted that the latter is necessary to obtain Kfs value for SPME analysis, 
but much less analyses were needed since the Kfs value should be the same 
for the whole sample; on the contrary, the traditional LE needs to be 
performed for every sampling site in each sample.  
 
Table 6.1. Summary of the in situ SPME results for OTA occurrence in the 
three cheese samples. Cheese 1: the aged Cheddar cheese with a mould 
stain. Cheese 2: the aged Cheddar cheese without mould stains. Cheese 3: 
the “no name”® skim milk cheese 
Cheese # 
Sampling 
site *S-con(ng/cm3) SD ** L-con.(ng/cm3) SD 
1 $1(close) 42 5.2 39 3.7 
 &2 (far) 20 3.5 18 2.1 
            
2 1 11  1.4 13 1.3 
 2 12  1.6 12 1.5 
 3 11  0.8 10 1.1 
 4 12  1.5 11 1.2 
            
3 1 §nd  nd  
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 2 nd  nd  
 3 nd  nd  
  4 nd   nd   
Notes:  
* Sample concentration obtained by SPME technique; 
**  Sample concentration obtained by Liquid Extraction echnique; 
$ The #1 sampling site that is close to the mould stain in the cheese; 
& The #2 sampling site that is further than #1 site to the mould stain in the 
cheese; 
§ Non-detectable. 
             
 In addition, to confirm the identity of OTA in real cheese samples, 
two transitions m/z 402.1/357.9 and 402.1/314.0 were used for OTA, in 
addition to LC retention time. Fig. 6.7 shows the cromatogram of OTA and 
OTB by LC-MS/MS. 
Compared to the previous studies,19-20 this work provides a simple but 
effective means to conduct in situ analysis of pH dependent ionic analytes in 
semi-solid food matrix.  
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Figure 6.7.  The chromatogram of the OTA and OTB by the LC/MS-. The 
Peak with a retention time of 2.8 min is for OTB, the standard. The Peaks with 
retention at 3.4 min are for OTA, among which the taller one is from the transition 
of m/z 402.1/357.9, and the shorter peak is for 402.1/314.0. 
 
Compared to the previous studies,19-20 this work provides a simple but 
effective means to conduct in situ analysis of pH dependent ionic analytes in 
semisolid food ascribed to the effectiveness of treating the miniaturized 
carbon-tape fibers with acids and the proved merit that the kinetic 
calibration is inherently more accurate than calibrtion curve method in 
complicated sample matrix.  
 
6.4 CONCLUSION  
 
6.4.1 Conclusion 
In situ SPME method was achieved by the acidification of the 
extraction phase with aqueous HCl solution at pH 2 which improved the 
extraction sensitivity of the fiber primarily because the analyte was a weak 
acid and in addition to decreasing analyses time. A new on-fiber kinetic 
calibration was developed by using OTB as an internal standard. The 
suitability of the OTB as an effective internal stand rd was demonstrated by 
comparing the kinetic behavior of OTA and OTB and showing the 
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consistence of their time constants (a values). In addition, the utilization of 
the miniaturized SPME with enhanced spatial resolution made it possible for 
the in situ analysis in a small-sized sample. Interestingly, the spatial 
distribution of the OTA concentrations in cheese sample and the 
concentration change over time can be used to find i  there is active OTA 
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The detection of human pharmaceuticals and personal care products 
(PPCPs) in aquatic environments, and their accumulation in non-target 
aquatic organisms has been an area of increasing research interest in recent 
years.1-11 Elucidating the uptake and bioaccumulation profiles of 
environmental mixtures of pharmaceuticals is  essential to furthering our 
understanding of the environmental fate and ecological risks of these 
ubiquitously detected compounds. 1-4 The potential for PPCPs to exert 
adverse effects on exposed aquatic organisms such as fish has been well 
demonstrated 12-13. Traditional sampling and sample preparation techniques 
have been utilized to study the toxicology and distribu ion of pharmaceutical 
residues in various fish tissues, organs, and cell lines.1-3,14-15  However, 
these techniques are often unsuitable for tracking the dynamic processes of 
bioaccumulation and metabolism, which are integrated whole organism 
responses modulated in vivo by a myriad of pathways including inducible 
hepatic detoxifying enzymes and excretion mechanisms. 
 Recently, the simplicity and robustness of the solid-phase 
microextraction (SPME) technique has been applied to the in vivo 
determination of pharmaceuticals in fish.19 A significant advantage of SPME 
fibers is their ability to extract a variety of trace contaminants from fish 
tissues without lethal sampling. To date, only relatively large SPME fibers 
(10 mm in length) have been used, constraining their application to larger 
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tissues such as muscle. Further, the physical fibersiz  precluded the spatial 
resolution required for parallel assessments of contaminant distributions in 
adjacent tissues. Previous SPME studies in fish were also limited to single 
pharmaceutical exposures (carbamazepine and fluoxetine in single 
compound exposures) in what were essentially proof-of-principle studies.19 
Consequently, the performance of in vivo SPME techniques under 
multi-analyte scenarios (such as mixtures of PPCPs within municipal 
wastewater effluents) has not been evaluated.  
In this chapter, both muscle and adipose fin were simultaneously 
sampled using space-resolved SPME to determine the tissue specific 
bioaccumulation of compounds commonly detected in urban areas 
influenced by municipal wastewater effluents, industry and agricultural 
runoff. Adipose fin was chosen as a tissue of interest since it contains 
significantly more lipid than does muscle, and should differentially 
bioaccumulate lipophilic PPCPs relative to muscle tissue.20-21 To reflect the 
complex mixtures represented in environmental matrices, fish were exposed 
to a mixture of nine analytes including seven pharmaceuticals belonging to 
three therapeutic classes: lipid regulators from the fibrate group (gemfibrozil) 
and statin group (atorvastatin), non-steroidal anti-inflammatory drugs 
(ibuprofen, diclofenac, and naproxen), and anti-depressives (fluoxetine and 
carbamazepine), plus the pesticide atrazine and the hormone-disrupter 
bisphenol A (BPA) from the polymer industry. Consequ ntly, this study 
 154
broadly evaluates the application of Sr-SPME techniques for assessing the 
bioaccumulation of contaminants in fish under contrlled exposure 
scenarios.  
  
7.2 EXPERIMENTAL SECTION 
 
7.2.1 Chemicals and Materials 
All aqueous solutions were prepared using de-ionized water obtained 
from a Barnstead Nanopure water system. All chemicals purchased were of 
the highest possible purity and used without further purification. 
Gemfibrozil, atorvastatin, ibuprofen, carbamazepine, diclofenac, naproxen, 
and bisphenol A (BPA) were purchased from Sigma-Aldrich (Oakville, ON, 
Canada). Fluoxetine, lorazepam, and atrazine were obtained from Cerilliant 
Corp (Round Rock, TX). The isotope labeled standards were purchased from 
CDN isotopes Inc. (Pointe-Claire, Quebec, Canada). Stock solutions were 
prepared in methanol and stored at -20 °C. HPLC grade acetonitrile for the 
HPLC mobile phase, methanol for standards preparation and desorption 
solution, formaldehyde, ethanol and acetic acid (glacial) were purchased 
from Fisher Scientific (Unionville, ON, Canada). 
 
7.2.2 Preparation and Characterization of Sr-SPME Fibers 
Home-made PDMS fibers were employed as the extraction phase for 
the in vivo sampling. Helix medical silicone tubings with a 0.31 mm ID and 
 155
0.64 mm OD (Carpinteria, CA) were used as the SPME coating, and 3.5 cm 
long stainless steel wires, 0.483 mm in diameter were purchased from Small 
Parts Inc. (Miami Lakes, FL) to serve as the internal support for the SPME 
fibers. The silicone tubing was cut into 1 mm long segments and the steel 
wire was carefully introduced into two tubing segments forming discrete 
sheaths. The distance between the two segments was adjusted to 4 mm after 
wetting with methanol. The resultant SPME fiber contai ed 2 separate 1 mm 
coating segments with a 4 mm space between them (Fig. 7.1A). All fibers 
were pre-conditioned in 100% methanol for 24 h, andthen in sterile pure 
water for 2 h to remove the methanol. Before in vivo application, each fiber 
was put into a polypropylene microcentrifuge tube and stored at -20 °C. 
A systematic characterization was completed to determine the 
extraction time profile, desorption time profile, any biofouling effect during 
extraction, and dynamic range. The characterization experiments were 
performed in standard spiked phosphate buffered saline (PBS, pH 6.8), 1% 
agarose gel medium, and dorsal-epaxial fish muscle tissue (~ 1 g) to 
optimize the experimental conditions for in vivo sampling.  
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Fig. 7.1. Configuration of the segmented SPME fiber. A: the fiber for in vivo 
use. B: the fiber ready for desorption in organic solvent. 
 
It was found that the inter-fiber variation was around 8-15%, largely 
attributable to the small size of the coating segments. When using 
home-made fibers, the smaller the fiber size, the bigger the inter-fiber 
variation. This variation was corrected by monitoring the amount of 
lorazepam extracted from a 50 µg/L aqueous standard solution by each 
coating segment within 30 min. As the amount of analyte extracted by a 
fiber is determined by its volume under fixed conditions, the difference in 
extracted analyte is a surrogate for variations in fiber volume. In this 
experiment, the upper coating segment must be moved t  the opposite end of 
the wire (leaving a 5 mm space at the tip) in order to differentiate the two 
1 mm 
Upper coating segment 
4 mm 
Tip coating segment 
A B 
Upper coating segment 
Tip coating segment 
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segments by virtue of their positions (Fig. 7.1B). The 30 min extraction and 
desorption experiment was performed in two successiv  rounds, each 
specific for one of the two fibre coating segments. The second extraction 
was performed after finishing the first round and reversing the direction of 
the wire to expose the second coating segment to the standard solution. Both 
the extraction and desorption experiments were conducte  in 96-well plates. 
Desorption of the extracted analytes from the fiber coating was performed in 
the same way as extraction but each well contained 100 µL of methanol, 
with each segment positioned at the two ends of the wir  sequentially 
desorbed into methanol within individual wells of the 96 well plate.  
In order to evaluate intra-fiber consistency, the same batch of fibers 
was used in 4 consecutive extraction-desorption cycles, yielding an 
intra-fiber variation of around 5%, which was deemed acceptable. Further, 
the results indicated that 30 min was a sufficient desorption period for the 
fibers when immersed in 100 µL methanol with agitation at 150 rpm on an 
orbital shaker.   
Another important step was to characterize any biofouling potential 
associated with sampling in fish tissues. The fouling effect was investigated 
by comparing the extraction behaviors of the fibers in direct contact with 
and in the absence of contact with fish tissue samples. Specifically, we 
conducted a series of static extractions in standard solution containing 50 
ng/mL of both carbamazepine and fluoxetine in PBS buffer over different 
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time intervals (5, 10, 20, 30, 60, 90, and 120 min) to develop two time 
profiles with two groups of fibers. One group was the normally 
pre-conditioned home-made PDMS fibers; the second being identical fibers 
exposed to tissue. The latter treatment first introduced the preconditioned 
fibers into muscle tissue specimens for 30 min. Then the fibers were twice 
rinsed with de-ionized water and wiped with Kimwipe® tissues prior to 
implementing a 30 min static extraction in standard solutions. With the time 
profiles, both the extracted amount in equilibrium (a thermodynamic 
parameter determined by the partitioning coefficient) and the time constant 
(a kinetic parameter) could be compared.   
 
7.2.3 Quantification with LC/MS-MS 
     An Agilent 1200 HPLC/MDS Sciex Q-trap 3200 tandem MS system 
was used for the analysis of the pharmaceuticals and the isotopic standards. 
For negative ESI MS analysis, the separation is carried out by using a 4.6 × 
150 mm Supelcosil LC-18 column with a 5 µm particle size (Supelco Corp., 
Bellefonte, PA). Gradient elution was performed with a flow rate of 0.8 mL 
min-1 for separation with mobile phase (A) HPLC grade water (100%) with 
5 mM ammonium acetate, and (B) HPLC grade methanol. The gradient 
started with 10% B for the first 0.5 min, ramping to 60% B in 0.01 min, and 
then linearly increasing to 100% B over 7.5 min. The 100% B mobile phase 
was then held for 3 min before decreased to 10% B over 0.01 min. This 
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provided a total 11 min run time including reconditioning of the column. For 
the positive ESI MS analysis, the gradient started with 60% B for the first 
0.5 min, ramping to 80% B in 0.01 min. The mobile phase was then linearly 
increased to 100% B over 5.5 min and held for 0.5 min before decreasing to 
60% B in 0.5 min. The total run time including column reconditioning was 8 
min. The resultant chromatograms are shown in Fig. 7.2. 
  For quantification, the main mass spectrometer analyte parameters 
were optimized and are summarized in Table 7.1. The MS parameters for the 
isotope labeled standards were similar to their non-labeled analogues and are 
consequently not provided in the table. The instrumental detection limit 
(IDL) for each analyte is shown, and generally, the positive ESI was more 
sensitive than the negative ionization. Instrument performance was 






XIC of +MRM (8 pairs): 216.2/174.3 amu from Sample 5 (20ppb) of Shine-last water SPE-pos.wiff (Turbo Spray) Max. 3.6e4 cps.



























XIC of -MRM (11 pairs): 204.9/160.9 amu from Sample 5 (20ppb) of Shine-last water SPE-neg.wiff (Turbo Spray) Max. 8210.0 cps.
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A: Positive ESI analytes 
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Table 7.1. MS Instrumental detection limits (IDL), Declustering potentials 
(DP), Entrance potentials (EP): Collision energies (CE), Collision cell exit 
potentials (CXP) for study analytes: DP, EP, CE, and CXP are provided as 
voltages. 
Compound Use Transition DP EP CE CXP IDL*  
ESI POSITIVE ANALYTES 
Atrazine pesticide 216/174 67 3.8 27 2.4 0.1 
Fluoxetine antidepressant 310/44 48 2.9 44 7 0.2 
Atorvastatin cholesterol lower 559/440 83 5.9 32 22 0.7 
Carbamazepine anti-seizure 237/195 55 4.9 51 2.7 0.05 
ESI NEGATIVE ANALYTES 
Gemfibrozil antilipemic 249/121 -55 -2 -17 -3 0.15 
Naproxen anti-inflammatory 229/169 -29 -1.9 -25 -4 0.3 
Diclofenac anti-inflammatory 294/250 -46 -2.5 -15 -2 0.4 
Ibuprofen analgesic 205/161 -41 -2.6 -11 -1 0.3 
Bisphenol A hormone-disrupter 227/212 -53 -10 -28 -5 1.0 
 
7.2.4 In vivo Sampling with Sr-SPME 
Municipal de-chlorinated water (with chlorine and chloramine residuals 
removed and/or stabilized by aeration and Big Al’s Aquarium Water 
Conditioner (10 mL:40 L,  Woodbridge, ON), respectively) was used for 
all fish experiments. All experimental procedures involving animals were 
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conducted in the Biology Wet-lab Facility at the University of Waterloo in 
accordance with protocols approved by the institutional Animal Care 
Committee (AUP # 07-16).  The juvenile rainbow trou (Oncorhynchus 
mykiss) used in this study were 19.8 to 24.5 cm in length and 80.0 to 134.2 g 
in weight (n = 20). Of these 20 fish, nine were divi ed into three groups (3 
fish /34 L aquaria) and exposed for 8 d to water spiked with the analyte 
mixture (atorvastatin, atrazine, BPA, carbamazepine, diclofenac, fluoxetine 
gemfibrozil, ibuprofen, and naproxen; 3 ng/mL of each compound dissolved 
in 100 uL of methanol). Daily renewals of test soluti ns on subsequent 
exposure days replaced half the exposure water volume (17 L) with analytes 
replenished in test solutions via their addition within 50 uL of methanol. The 
three 34 L exposure aquaria containing the analyte mixtures (3 fish each, 9 
total) were exposed alongside a solvent control (3 fish) with 8 additional fish 
held as clean water controls. Water quality was monitored daily and 
maintained at conditions considered suitable for trut (temperature 12.4 ± 
0.05 °C; dissolved oxygen 9.64 ± 0.15 mg/L; pH 7.79 ± 0.04; ionized 
ammonia 54.9 ± 3.6 µg/L).   
The in vivo sampling was conducted every two days for a period of 8 
days using pre-equilibrium SPME with kinetic calibration for quantitation. 
The sampling procedure with kinetic calibration was similar to that 
described previously, 17 with minor modifications. Briefly, after the fish was 
anaesthetized (0.1% ethyl 3-aminobenzoate methanesulfonate) until loss of 
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vertical equilibrium, a 20 gauge needle was applied to pierced the fish at an 
angle approximately 30-45˚ (from the vertical) through the adipose fin and 
into the dorsal-epaxial muscle penetrating the lattr tissue approximately 0.8 
cm in depth. Subsequent to removing the needle, the Sr-SPME fiber was 
introduced into the hole until the two coating segmnts were positioned in 
muscle and adipose fin tissue respectively, as shown in Fig. 7.3. The fiber 
coating was embedded in the tissue and the close contact between the tissue 
and fiber prevented water entry. After fiber placement the fish was put into 
the fresh reference water for 8 min. Then the fish was anaesthetized again 
prior to removing the fiber coating, for a total contact time between the fiber 
and tissue of 10 min. After a brief rinsing with de-ionized water and drying 
with a Kimwipe® tissue, the fiber was put back into the polypropylene 
microcentrifuge tube labeled with the fish number and date.  
For parallel desorption of the analytes from the fiber, the two coating 
segments were positioned onto opposite ends of the ste l wire by again 
moving the upper segment along the wire. Then the wir as cut into two 
sections, each containing one coating segment with eac  segment desorbed 
into 100 µL of methanol within a 200- µL polypropylene insert positioned in 
a 2 ml amber vial (National Scientific, Rockwood, TN). The vials were 
capped and agitated at 140 rpm for 2 h, after which the wires with coating 
segments were removed with a magnet, and 60 µL of water containing 20 
µg/L lorazepam as the internal standard was added to the methanol followed 
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by a brief votex.  Lorazepam was used to calibrate the sample loss during 
LC/MS-MS quantification. It deserves noting that the parallel desorption 
was adopted for the in vivo sampling experiment, in which the wire with 
coatings was cut to two sections to be fitted into the insert in the 2-ml vial 
for desorption. However, the in series procedure of xtraction and desorption 
was used for monitoring the inter-fiber variation, as described before in the 
“Preparation and Characterization of Sr-SPME Fibers” part, where only the 
position of coating segments was changed but the fiber was intact so that it 
could be reused for the following in vivo sampling. On the contrary, the 




 Fig. 7.3. Placement of the segmented SPME fiber into adipose fin and muscle 
tissue. 
 
Steal wire support 
SPME coating segment in adipose 
SPME coating segment in muscle 
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7.2.5 Determination of Free Concentrations by Equilibrium SPME and 
Total Concentrations by Organic Solvent Extraction 
The free concentrations of the analytes of interest in muscle and 
adipose tissue were analyzed using the equilibrium SPME technique, while 
the accumulated tissue concentrations after 8 days of exposure were 
determined (following lethal sampling) by organic solvent extraction with 
methanol and calibration by isotope dilution. These procedures will both 
validate the sensitivity of the SPME technique, andcalculate the distribution 
coefficient (Kfs) between the fiber coating and the tissue sample.  
The in vitro tissue SPME analysis utilized a clean fiber with a single 
coating segment (2 mm in length) for insertion into an excised piece of 
muscle or adipose tissue. The tissue and fiber were h ld at 4 ˚C for 15 h 
under static conditions; conditions deemed sufficient to achieve equilibrium 
based on extraction time profiles from earlier in vitro experiments. After 
equilibration, the fiber was removed from the tissue and rinsed briefly with 
de-ionized water prior to desorption in methanol. Since the fiber length is 
only 2 mm, the amount of analyte extracted from thesample tissue is 
considered to be negligible.  
 The total analyte concentrations accumulated in fish tissues were 
determined using traditional liquid extraction (LE) with methanol. Whole 
tissues were prepared for LE analysis by cutting the sample into 
approximately 2 mm2 pieces with a scalpel on a chopping board covered 
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with alumina foil with mass determined in an analytical balance following 
transfer to a pre-weighed microcentrifuge tube. Then 500 µL of methanol 
containing 20 ng/mL isotopically-labeled standard mixture was added into 
each tissue sample and homogenates generated (4 x 20 seconds/round with a 
Teflon homogenizer). Following a brief vortex, low-temperature 
centrifugation (4 ˚C, 15000 rpm, 30 min) separated the tissue pellet from the 
supernatant, the latter of which (100 µL) was transferred into a 200 µL 
polypropylene insert within a 2-mL amber vial. Finally, 60 µL of water 
containing 20 µg/L lorazepam (the internal standard) was briefly votexed 
into the mixture to produce the final sample for instrumental analysis. The 
relative recovery of the isotope standards following liquid extraction of 
muscle and adipose tissue of control fish was used to assess extraction 
efficiency. 
 
7.2.6 Water analysis with SPME and SPE 
To determine the bioaccumulation factor of each comp und in the 
target tissue, SPME techniques were employed to monitor the concentrations 
of the pharmaceuticals in exposure aquaria water. To facilitate calibration by 
standard addition, every 40 ml sample was divided into two 20 ml aliquots. 
One aliquot was spiked with 60 ng of each of the 9 standards dissolved in 
methanol, while the other received the same amount f pure methanol to 
compensate for any solvent effects. Concentrations of each unknown were 
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quantified by comparing the signal intensity of spiked and un-spiked 
samples. Three fibers with only a single coating sem nt were used to 
monitor every water sample. The extraction was performed at 140 rpm on an 
orbital shaker for 30 min, and the desorption procedur  and reagents were 
the same as previously described. To evaluate the accur cy of the standard 
addition method, a blank sample was divided into four 10 ml aliquots and 
spiked with 0, 30, 45, and 60 ng of standards respectively. The linearity (R2) 
of the regression line and the averaged standard deviation (RSD) from all 
three points were used to assess relative recovery.  
     To evaluate the efficacy of SPME for water analysis, solid phase 
extraction (SPE) was performed alongside the SPME assessments. Water 
samples were extracted with the Oasis HLB cartridges (Waters Corp., 
Millford, MA) on an automated SPE system (12-port Visiprep vacuum 
manifold coupled to a vacuum pump from Supelco (Bellefonte, PA)). The 
SPE cartridges were pre-conditioned (in the order) with 5 mL of methyl 
tertiary butyl ether (MTBE) MTBE, 5 mL of methanol, and 5 mL of HPLC 
grade water. For calibration by the isotope dilution method, 50 µL of 100 
ug/L isotopically-labeled standard mixture was added into each of the 500 
mL water samples prior to SPE extraction. The sample was introduced into 
the cartridge at a flowrate of 15 mL min-1; after sample passage, the 
cartridges were rinsed with 5 mL HPLC grade water and dried under 
vacuum for approximately 15 min. When the SPE cartridges were dry, 
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analytes were eluted with 5 mL of pure methanol and5 mL of 10:90 (v/v) 
methanol : MTBE, sequentially. The eluted extract was then evaporated 
completely and re-constituted with 500 µL of methanol reconstitute solution 
containing 75 ug/L lorazepam as internal standard. Recovery was 
determined using 500 mL water samples from the control tanks spiked with 
the same known amount of deuterated standard mixture (5 ng of each 
standard) to determine analyte recovery with the SPE method. 
 
7.3 RESULTS AND DISCUSSION  
Previous studies demonstrated that the SPME technique can be easily 
applied to in vivo analysis of plants and animals tissues, including those of 
fish. 19,22-25 This technique exhibits high efficiency, simplicity, and 
convenience compared to conventional sampling and sample preparation 
methods. However, SPME techniques have previously been applied only to 
relatively large, uniform tissue samples such as venous blood,23-25 fish 
muscle,19 and porpoise blubber,26 while the current study demonstrates the 
possibility of in vivo SPME for high-throughput and space-resolved 
applications. Further, the present study demonstrates the utility of SPME for 
the in vitro sampling of water and tissue samples, and provides a 
comparative study between SPME and more established techniques such as 
SPE and LE.  Thus this report provides a comparative o erview of the 
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relative merits of several important sampling methodol gies common in 
environmental toxicology. 
 
7.3.1 Development of Segmented Sr-SPME Fibers  
The choice of fiber coating material in any SPME study is based on the 
requirements of the in vivo experiment and made with consideration of 
required attributes such as biocompatibility, sensitivity, and robustness. In 
the present study, these factors were important, but the focus was on 
miniaturizing the fibres for tissue specificity while ensuring reproducibility 
was not compromised.  
In order to obtain an accurate evaluation of the fat of pharmaceuticals 
in a small-sized fish tissue, miniaturization of the SPME fiber dimensions is 
a must. In the present study, the fiber length was reduced to 1 mm, which 
could effectively be utilized to monitor the analyte bioaccumulation in a 
small area of approximately 1 mm3. The miniaturized fiber combined with 
the segmented design made it possible to probe two separate sampling sites 
in a small fish using one fiber with two mini-coating segments. Additionally, 
the sensitivity of the fiber to non-polar pharmaceuticals could be guaranteed 
with the strong affinity of the PDMS coating for non-polar molecules. The 
extraction behavior of the mini-coating in standard solution showed that 
detection limits during a 10 min static extraction were identical for 
gemfibrozil, carbamazepine, and ibuprofen at 0.2 ng/mL , and 0.05, 1, 4, 5, 7, 
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and 12 ug/mL for atrazine, fluoxetine, diclofenac, naproxen, atorvastatin and 
BPA, respectively.  
The potential for biofouling was investigated through extraction time 
profiles using tissue-treated and non-treated fibers, which indicated no 
significant impairment of the fiber extraction ability resulting from exposure 
to fish tissue (Fig.7.4). In addition, an effective method to correct the 
inter-fiber variation was proposed which reduced the RSD from 14% to 
6.5% based on 100 coating segments. The reduction in RSD of 7.5% was 
found to be due to inter-fiber variations, with the r maining 6.5% 
attributable to experimental error including variations in sampling procedure, 
instrumental analysis, etc. 
 
7.3.2 Calculating Distribution Constant (Kfs)  
      As discussed in previous papers, it is necessary to determine the 
product of the analyte Vf and Kfs to obtain total sample concentrations using 
on-fiber standardization.27 In this report, the Kfs • Vf   product was obtained 
by combining the data from equilibrium SPME and conventional LE 
techniques for the in vitro tissue sample based on the following equation:   
seffs CnVK /=                           (7.1)     
where ne is the amount of analyte extracted using the equilibrium SPME 
approach and Cs is the analyte concentration in the sample tissue. Herein, we 
used the equilibrium SPME method (15 h equilibration time in vitro) to 
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obtain ne, and then measured the sample concentration, Cs, with traditional 
organic solvent (methanol) extraction. This traditional LE approach was 
calibrated using the isotope dilution method as an internal calibration 
standard to increase quantitation accuracy by compensating for tissue matrix 
effects. Using this approach, the relative recoveries calculated from control 
tissue samples spiked with isotope standards were 94.4-103.1%, which 
demonstrated the accuracy and reliability of the method.  
Listed in Table 7.4, The Kfs values, specially refered to as Kfm and Kfa 
for distribution coefficient of the analyte between the fiber coating and 
muscle or adipose fin tissue respectively in this study, were calculated with 
the products Kfs • Vf devided by the fiber volume of the coating segments. 
When compared with literature Kow values, the roughly proportional 
relationship is readily obvious; an observation consistent with other 
environmental samples (water and air) from previous st dies.28-30 
 
7.3.3 Water sampling with SPE and SPME   
Fish exposure water samples analyzed by both SPE and SPME did not 
differ significantly in their respective estimates of waterborne concentrations 
of any analyte examined (Table 7.2). The standard addition method used for 
calibrating the SPME data was highly accurate as evidenced by the linearity 
of the calibration curve regression line (R2 = 0.992), and average RSD (less 
than 6.3%).  
 172
As with the LE tissue samples, the isotope dilution technique was 
employed to calibrate the SPE exposure water analysis. U ually, the easiest 
way to calculate an analytes concentration is using the response ratio of the 
analyte relative to its deuterated standard to multiply by the spiked 
concentration of the standard in the sample matrix. The underlying 
assumption for this method is that the response factor ratio of the analyte 
would be the same as its’ deuterated analogue, with an ideal value of 1. 
However, as demonstrated in Table 3, this relationship i  not always the case, 
as in the present study the response ratio for the analyte relative to its’ 
deuterated standard differ significantly (range 0.68-1.46).  To compensate 
for the apparent response difference between analytes and their deuterated 
analogues, the response ratio should not be assumed as 1, but be corrected 
by the measured response factor ratio on a compound-specific basis.   
The SPE procedure was much more time (15 h) and labor intensive 
than the SPME method (2-3 h) when measuring analyte concentrations in 
fish exposure water. However, SPE  has higher sensitivity than SPME in 
that the SPE method could detect trace levels of analytes in the control water 
(shown in Fig. 7.5), which were non-detectable using the SPME technique. 
The heightened sensitivity of the SPE technique is attributable to the 
exhaustive extraction method inherent to this approach, while 
equilibrium-based SPME sampling typically yields lower sensitivities. 
Despite the higher detection limits associated with the SPME technique, this 
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method can be used to monitor free (biologically avail ble) analyte 
concentrations within complex matrices, an application not suited for SPE 
analysis. 23,27-28 
 
7.3.4 Study the Tissue Specific Bioaccumulation with Sr-SPME 
With the space-resolved SPME technique, the accumulation of 
pharmaceuticals and bioactive analytes in muscle and adipose tissue were 
determined simultaneously, demonstrating the utility of the in vivo technique 
for tracking tissue burdens over time (Fig. 7.6). To generate these datasets, 
total tissue analyte concentrations were measured by LE at the experiments 
conclusion (8 d), which in turn were used to calculate distribution 
coefficients for muscle and adipose tissue, as shown in Table 7.4. Thereafter 
the total concentrations of the pharmaceuticals for each sampling interval 










Table 7.2. Total analyte concentrations in water samples as determined 
using SPME and SPE techniques (n = 3; mean ± SD; unit: ng/mL) 
  Ibuprofen Naproxen Diclofenac 
Day 
number 
SPME SPE SPME SPE SPME SPE 
2 2.88±0.14 2.82±0.50 2.89±0.12 2.98±0.11 3.02±0.11 2.92±0.25 
4 2.75±0.11 2.73±0.12 2.81±0.07 2.81±0.15 2.89±0.10 2.83±0.19 
6 2.68±0.07 2.83±0.14 2.73±0.17 2.79±0.06 2.83±0.12 2.80±0.17 
8 2.87±0.15 2.79±0.11 2.69±0.11 2.92±0.12 2.97±0.17 2.88±0.13 
 
  Atrazine Fluoxetine Atorvastatin 
Day 
number 
SPME SPE SPME SPE SPME SPE 
2 2.79±0.13 2.88±0.17 2.78±0.27 2.87±0.12 2.85±0.13 2.90±0.16 
4 2.64±0.23 2.68±0.16 2.59±0.19 2.64±0.15 2.41±0.24 2.58±0.13 
6 2.77±0.12 2.63±0.18 2.67±0.13 2.76±0.11 2.36±0.18 2.63±0.17 
8 2.66±0.20 2.67±0.15 2.56±0.22 2.77±0.14 2.53±0.20 2.62±0.21 
 
  Bisphenol-A Gemfibrozil Carbamazepine 
Day 
number 
SPME SPE SPME SPE SPME SPE 
2 2.92±0.11 2.90±0.10 2.86±0.17 2.81±0.24 2.86±0.12 3.03±0.18 
4 2.74±0.21 2.71±0.25 2.65±0.13 2.73±0.21 2.81±0.07 2.87±0.17 
6 2.87±0.11 2.76±0.19 2.61±0.12 2.67±0.08 2.73±0.17 2.81±0.05 
8 2.08±0.23 2.22±0.21 2.65±0.23 2.37±0.16 2.69±0.11 2.91±0.16 
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Fig. 7.4. The sample concentrations of the reference water by using SPE method. 
The detection limits of SPE for ibuprofen, BPA, naproxen, gemfibrozil, diclofenac, 
atrazine, carbamazepine, fluoxetine and atorvastatin were 1, 10, 0.2, 0.15, 0.15, 
0.025, 0.05, 0.2 and 1 ng/L. 
  
Table 7.3. The response ratio for analyte over the same amount f its 
deuterated standard. 
Calculating the response factor ratio (RFR) 






































Fig. 7.5. The extraction time profiles with the original fiber and muscle-dipped 
fiber coating. 
 
Of the nine analytes comprising the exposure test mix ures, only five 
compounds (atrazine, gemfibrozil, CBZ, ibuprofen, ad fluoxetine) were 
detected in fish tissues by SPME and LE, while the remaining four analytes 
(atorvastatin, naproxen, BPA, and diclofenac) were not detected. There are 
several potential explanations for our inability to detect these analytes. One 
explanation is the detection limit of the instrumentation is simply 
insufficient to measure select analytes in fish tissues. However, as all 
analytes were persistent and detected in the exposure water, it would appear 
all compounds were equally available for uptake across the gills, but four of 
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the compounds simply did not bioaccumulate within fish tissues. Some of 
the lower log Kow compounds, or those which readily ionize may have be n 
rapidly excreted, and consequently only present in low concentrations in fish 
tissues. Alternatively, those analytes which could be quickly metabolized by 
fish would be present as the parent compound only at low concentrations.33 
Overall, while the sensitivity limits of the Sr-SPME technique may have 
precluded detection of some analytes, sensitivity should not have been a 
factor with the LE determination, suggesting the four compounds not being 
detected by LE are likely absent due to their excretion or metabolism rather 
than a lack of method sensitivity. Regardless, the fiv detected analytes 
represent widely used environmental compounds including two 
anti-depressant drugs, one anti-inflammatory, one analgesic and one 
pesticide constituting a diverse group of compounds requisite to assessing 
the efficacy of Sr-SPME as a robust detection technique in fish.  
Overall, there was a roughly proportional relationship between the Kfm 
(fiber-muscle tissue distribution) value and the Kow value for a specific 
compound; however, there were also exceptions. For example, the log Kow 
values for carbamazepine and atrazine were approximately equivalent (2.4 
and 2.34, respectively) but their Kfm values were markedly different (11 and 
790, respectively), which could be ascribed to several aspects. First, the 
distribution occurred in the organism should be different from that in water 
or air, since more biochemistry processes such as metabolism are involved 
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in the organism and make it complicated. Second, the composition of the 
tissue might vary along with the growth and development of the juvenile 
fish. Nevertheless, the current SPME technique may provide a simple means 
to study the in vivo dynamic distribution. 
Bioaccumulation factors (BAF) were calculated based on the total 
concentrations of the compounds in the tissue and exposure aquaria. 
Generally, the results were consistent with previous literature values4, 19 
demonstrating a positive relationship between BAFs, including BAFm and 
BAFa, and log Kow values. The correlation could be further improved by 
using lipid normalized analyte concentrations if the amount of lipid in the 
tissue can be accurately determined.21 The positive correlation observed in 
the present study between BAFm and BAFa using Sr-SPME and LE, supports 
previous findings in flathead catfish (Pylodictis olivaris).21 However, this 
basic relationship is modified by a variety of factors including compound 
ionization, metabolism, the physiological status of the fish, and also the 
composition of the pharmaceutical mixtures. Previous studies have 
demonstrated that ionization of analytes at physiological pH values can 
strongly affect bioaccumulation potential, and would vary with the pKa of 
the parent compound and any metabolites or transformation products 
present.4 For example, the pKa value of carbamazepine is 13.4 and ibuprofen 
is 5.2, which could affect both their polarity/ionization capacity and 
bioaccumulation potential.36 Further, interactions between different drugs 
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could modify metabolism of co-occurring analytes. For example, the 
hypolipidemic drugs atorvastatin and gemfibrozil modify lipid metabolism 
and may influence the bioaccumulation of high Kow analytes such as 
fluoxetine. 
Table 7.4. The distribution and bioaccumulation factors of the test 
compounds after eight exposure days. 
 Atrazine Gemfibrozil CBZ Ibuprofen Fluoxetine 
Kf-m 703.2 15.4 11.2 10.3 25.2 
Kf-a 404.3 1.1 5.0 0.9 0.8 
log(Kow)
* 2.34 4.77 2.40 3.97 4.64 
BAFm 0.4 0.3 0.5 1.5 58.1 
BAFa 5.2 20.1 4.3 13.8 112.1 
 
























































































































































 Fig. 7.6. The bioaccumulation of gemfibrozil, ibuprofen, atrazine, carbamazepine, 
and fluoxetine in fish muscle and adipose fin. M: muscle tissue concentrations by 
SPME. A: adipose fin concentrations by SPME. M-LE: muscle tissue 
concentrations by LE. A-LE: adipose fin concentrations by LE. 
 
7.4 CONCLUSION  
7.4.1 Conclusion 
The Sr-SPME technique was developed to facilitate the in vivo analysis 
of tissue-specific bioaccumulation of pharmaceuticals and pesticides in fish 
tissues. The segmented miniaturized configuration of the probe offered the 
requisite spatial resolution for in situ application in small fish. The medical 
grade PDMS fiber coating proved to be biocompatible and highly sensitive. 
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A standard on-fiber calibration was adopted for accurate quantification 
within short exposure durations. With this approach, the bioaccumulation of 
pharmaceuticals and other bioactive analytes in adipose and muscle tissue 
was simultaneously determined. The results demonstrated differential (but 
correlated) bioaccumulation of four pharmaceuticals (gemfibrozil, CBZ, 
ibuprofen, and fluoxetine) and one pesticide (atrazine) within muscle and 
adipose tissue. Distribution coefficients were determined using equilibrium 
SPME combined with LE for in vivo monitoring of the analyte 
concentrations in semi-solid fish tissues. SPME and SPE determinations of 
aqueous analytes were in good agreement. However, the SPME method is 
much simpler and faster than SPE, although the SPE technique demonstrated 
superior sensitivity. Overall, the Sr-SPME technique is a novel SPME 
application that is simple to deploy, with good spatial and temporal 
resolution, sensitivity, and capacity to simultaneously monitor multiple 





Summary and Perspective 
 
8.1 Summary 
   Although solid phase microextraction (SPME) has gained wide 
applications from in vitro environmental investigations to in vivo 
pharmacokinetic studies, it is still difficult to monitor fast concentration 
change over time at a specific spot or sampling site in a heterogeneous 
system, where the sampling technique should have high temporal resolution 
and spatial resolution. Here, the temporal or spatial resolution of the SPME 
technique is referred to as its capability to clearly resolve two different 
concentrations that are close to each other temporally r spatially. Generally 
the temporal resolution of the SPME is determined by its response time or 
sampling time. Therefore, to improve the temporal resolution, it is necessary 
to reduce the sampling time. On the other hand, the spatial resolution of 
SPME is determined by the size of its extraction phase; so it could be 
improved by reducing the fiber size. However, the sampling time of SPME 
that determines its temporal resolution, should also be considered 
simultaneously, because the diffusion during a long sampling time tends to 
uniform the concentration distribution in the adjacent areas, thus making 
spatial resolution meaningless. Consequently, for SPME experiments, the 
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effect of reducing sampling time should be considere  together with 
shrinking the fiber dimension.  
It must be noted that reducing the sampling time and fiber dimension 
always result in compromised sensitivity, as shown in Eq. 1.08, and Eq. 1.10 
of Chapter 1. Therefore, in case of time- and space-resolved SPME, the 
sensitivity of the method must be carefully investiga ed in advance because 
the sensitivity of SPME sets the limits for sampling time and fiber 
dimension. In addition, the spatial resolution is dramatically affected by the 
diffusion of the analyte molecules in the sample matrix, as described by Eq. 
1.12 of Chapter 1. Hence, minimal sampling time must be evaluated to 
ensure the validity of an in situ analysis in a heterogeneous system.   
The goal of the research presented in this dissertation was not only to 
address the issues mentioned above but also to develop n w analytical 
methods that were more efficient and effective for in vivo studies using 
SPME. In order to achieve the goal, the research has been conducted in four 
steps. Briefly, the first step is the development of kinetic calibration for solid 
coating SPME coatings. One rationale is that the solid c ating SPME can be 
easily devised to have polar surface chemistry thus more suitable for 
sampling of polar pharmaceuticals, while liquid coating SPME normally has 
better affinity and sensitivity for nonpolar analytes. Furthermore, the kinetic 
calibration overcomes the inherit limitations of the traditional external 
calibration curve method and delivers accurate calibr tion for the in vivo 
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pre-equilibrium sampling. Later, the kinetic calibration was successfully 
applied to the in vivo pharmacokinetic studies; moreover, a series of 
simplified kinetic calibration was developed to improve not only the 
cost-effective but also the time-effective, or temporally resolved. The third 
step is the development of SPME technique with miniatur zed fiber coating 
and improved spatial resolution. Finally, the feasibility of the time-resolved 
and space-resolved SPME for in vitro study was demonstrated by studying 
the drug distribution in the onion bulb with highly heterogeneous structure 
and the toxin’s (i.e., Ochratoxin A) concentration distribution in the cheese 
and its change over time. Its efficacy for in vivo dynamic study was 
illustrated by investigating the tissue specific accumulation of 
pharmaceuticals in live fish. The detailed summary of the research is 
presented in the following paragraphs. 
The first work is to study the kinetics of adsorption and desorption of 
analytes onto and from the surface of porous solid SPME fibers. Theoretical 
model, based on the assumptions of steady-state diffusion in the boundary 
layer and quick distribution equilibrium on the interface between the fiber 
surface and sample matrix, was proposed. It was found that the adsorption 
kinetics provided a directly proportional relationship between the amount of 
analyte adsorbed by solid SPME fiber before the equilibri m and its initial 
concentration in the sample matrix. This observation indicates that 
quantitative analysis with porous solid SPME fiber can be performed by 
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pre-equilibrium extraction. Consequently, the kinetic calibration method was 
developed for accurate calibration in pre-equilibrium extraction using porous 
solid SPME fibers based on the symmetric relationship between adsorption 
and desorption. However, the quantification is limited within the linear 
range of the given fiber. For example, for diazepam in beagle whole blood, 
the linear range was 5 - 1000 µg/L, where 5 µg/L is the limit of detection. In 
addition, the rate for adsorption and desorption was found to be boundary 
layer-controlled. This suggested the importance and necessity of the kinetic 
calibration to compensate the agitation and matrix effect while using porous 
SPME fibers in pre-equilibrium extraction. Finally, the resulting kinetic 
calibration was used for drug analysis in clinical plasma and whole blood 
using Polypyrrole (PPY) fibers, and accurate results (relative recovery: 
91-101%) were obtained. 
The second work involved applying the kinetic calibration of SPME for 
in vivo sampling. The kinetics of desorption and adsorption of analytes from 
and onto the SPME fibers showed the feasibility of the kinetic calibration 
method for in vivo application. Furthermore, for determining the sample 
concentration, a simple method was proposed to calculate the main 
parameter, the product of Vf and Kf. To evaluate its validity, diazepam 
pharmacokinetics was studied with the PEG-C18 probes. Accurate 
metabolism information was obtained using PEG-C18 probes of large linear 
range (5-2000 µg/L) and high capacity (~1 ng), along with the fast extraction 
 187
time (2 min) defined by the kinetic calibration method. The results were 
comparable to the results of traditional blood drawing and chemical assay 
(LOD: 5 µg/L and linear range 5-2000 µg/L). Actually, with the improved 
temporal resolution, i.e., 2 min sampling time, there could be more sampling 
points for the pharmacokinetic studies, thus providing much more detailed 
information for the drug metabolism. The detection limit (0.5 µg/L) of the 
equilibrium sampling (10 min) was ten times lower than that (5 µg/L) of the 
pre-equilibrium sampling (2 min).   
Afterwards, a series of simplified calibration methods and sampling 
strategies were developed to improve its accuracy and utomation 
potentiality; meanwhile, the application conditions of these methods were 
investigated. Through studying the desorption kinetics of the preloaded 
standards from the SPME fibers, it was found that te time constant, a, is 
independent of the sample concentrations, but it is affected by the sample 
composition, sample agitation, fiber surface area and composition, and the 
distribution constant as described by eqs 2.11, 2.12, and 2.32. Consequently, 
the multiple time-points and isotope-labeled internal standard based 
traditional kinetic calibration approach was simplified to single time-point 
and non-isotope labeled standard calibration, further to single-standard 
calibration for multiple analytes and finally to a single-point self-calibrated 
SPME without using standards. The simplification was based on the 
assumption that the blood composition and agitation do not change 
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significantly during the 8-10 hour in vivo experiment. All the methods were 
verified by in vitro and in vivo experiments and validated by traditional 
blood drawing and chemical assay (no significant difference according to 
one-way ANOVA and the post-hoc Turkey’s test for multiple comparisons). 
The simplified calibration methods guaranteed the temporal resolution (2 
min vs. the 10 min sampling with equilibrium sampling), enhanced the 
quantitative applications of SPME for in vivo dynamic monitoring, and 
improved the multiplexing capability and automation potentiality for high 
throughput analysis. 
The spatial resolution of SPME was addressed in several aspects. 
Firstly, the sampling of the SPME with high spatial resolution was modeled 
in multilayered gel system with the mini-sized SPME fibers (1 mm in 
length), and the feasibility of the SPME for real application was 
demonstrated in an onion bulb, a heterogeneous system. The results agreed 
with that from the established microdialysis method (Table 5.1); but 
methodologically SPME was found to have higher sensitivity and resolution 
(SPME: LOD: 2.5 ng/mL; patial resolution: 1 mm. MD: LOD: 5 ng/mL; 
patial resolution: 4 mm), simpler implementation and more 
cost-effectiveness. Another in vitro study was performed using the 
miniaturized carbon-type fiber for in situ analysis of concentration 
distribution of Ochratoxin A (OTA) in a piece of semisolid cheese. The 
limits of detection and quantification for the 1 mm fiber in gel matrix were 
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1.5 and 3.5 ng/mL and the linear range was 1.5-500 ng/mL. It is interesting 
that the spatial distribution of the contaminant concentration and the 
concentration change with the time can be used to monitor the active OTA 
fungi in the cheese, i.e., an indicator of contamination source. The results 
were validated by liquid extraction (Table 6.1). Finally, the in vivo 
application of the space- and time- resolved SPME was demonstrated by 
studying the tissue-specific bioaccumulations of pharmaceuticals in fish 
adipose fin and muscle. With the segmented design of the SPME fibers, the 
pharmaceutical residues in fish muscle and adipose fin can be determined 
simultaneously with only one SPME fiber; thus increasing the throughput of 
the analysis. The in vivo assay showed good sensitivity, for example, the 
detection limits during a 10 min static extraction were identical for 
gemfibrozil, carbamazepine, and ibuprofen at 0.2 ng/mL, and 0.05, 1, 4, 5, 7, 
and 12 ug/mL for atrazine, fluoxetine, diclofenac, naproxen, atorvastatin and 
BPA, respectively. The results were validated by liquid extraction and solid 
phase extraction, as shown in Table 7.2 and Fig.7.6. And they were also 
comparable to the literature results. 
     The research presented here demonstrated the application potential of 
the time-and space- resolved SPME for in situ dynamic and static analysis in 
living systems, such as an i  vivo study and in a non-living system, such as a 




   The developed novel SPME technique has many important advantages, 
such as simple operation, cost-effectiveness and improved quantitative 
capability. But there are still some fields that deserve in depth exploration.  
    The first issue could be the matrix competition effect for solid coating 
SPME. Traditionally, researcher believed that that the competition effect 
could be eliminated or reduced by shortening the sampling time. But, the 
observed reduced competition is due to less competition or because of the 
fact that the analytical signal is not strong enough to reveal the competition. 
Other matrix effects on the sampling, for example, th  effect of biofouling, 
on the kinetic property of the SPME extraction, need to be addressed clearly.   
    Secondly, the extraction mechanism, absorption/adsorption or mixed 
mechanism needs to be studied. This is important because the answer could 
be used for accurate quantification. For example, it would be important to 
determine the surface area of a solid coating SPME fiber. 
    In addition, when many efforts have been put into the field to seek 
specific extraction sorbents, such as molecularly impr nted polymers, 
antibody or aptamer immobilized materials, there is less attention onto the 
universal extraction materials. The non-selectivity might have useful 
application, especially when the fiber is used for metabolomic studies.   
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